Document:

<PAGE>

                                                                     Exhibit 4.3

         VOID AFTER 5:00 P.M., NEW YORK CITY
         TIME, ON NOVEMBER ___, 2008
         (UNLESS EXTENDED PURSUANT TO SECTION 2 HEREOF)

         THIS WARRANT AND THE SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE
         NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE
         "SECURITIES ACT"), OR THE SECURITIES LAWS OF ANY STATE OF THE UNITED
         STATES OR ANY OTHER JURISDICTION. THE SECURITIES REPRESENTED HEREBY MAY
         NOT BE OFFERED, SOLD OR TRANSFERRED IN THE ABSENCE OF AN EFFECTIVE
         REGISTRATION STATEMENT FOR THE SECURITIES UNDER APPLICABLE SECURITIES
         LAWS UNLESS OFFERED, SOLD OR TRANSFERRED PURSUANT TO AN AVAILABLE
         EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THOSE LAWS.

                                    Right to Purchase [_____] Shares of
                                    Common Stock, par value $.001 per share

Date: September ___, 2003

                              LEVEL 8 SYSTEMS, INC.
                               SERIES D-2 WARRANT

         THIS CERTIFIES THAT, for value received, [NAME], or its registered
assigns, is entitled to purchase from Level 8 Systems, Inc., a corporation
organized under the laws of the State of Delaware (the "COMPANY"), at any time
or from time to time during the period specified in Section 2 hereof
[______]fully paid and nonassessable shares of the Company's common stock, par
value $0.001 per share (the "COMMON STOCK"), subject to adjustment as provided
herein. The exercise price per share for which this Warrant (as defined below)
is exercisable shall be fixed on the Exercise Date, (as hereinafter defined) and
shall equal the lesser of (i) $0.20, subject to adjustment as provided herein,
or (ii) the average Market Price (as hereinafter defined) of the Common Stock
for the five (5) trading days ending on the day immediately preceding the
Exercise Date (the "Exercise Price"). The shares of Common Stock purchasable
hereunder are referred to herein as the "WARRANT SHARES". The term "WARRANT" and
all references thereto, as used throughout this instrument, shall mean this
instrument as originally executed, or if later amended or supplemented, then as
so amended or supplemented. This Warrant is being issued by the Company along
with similar warrants designated as Series D-1 Warrants (the "OTHER WARRANTS"
and, together with this Warrant, the "WARRANTS") pursuant to that certain
Securities Purchase Agreement, dated as of March__, 2003, by and among the
Company and the other signatories thereto (the "SECURITIES PURCHASE AGREEMENT").

<PAGE>

This Warrant is subject to the following terms, provisions and conditions:

         1. Manner of Exercise; Issuance of Certificates; Payment for Shares.
Subject to the provisions hereof, including, without limitation, the limitations
contained in Section 8 hereof, this Warrant may be exercised by the holder
hereof, in whole or in part, by the surrender of this Warrant, together with a
completed exercise agreement in the form attached hereto (the "EXERCISE
AGREEMENT"), to the Company during normal business hours on any business day at
the Company's principal executive offices (or such other office or agency of the
Company as it may designate by written notice to the holder hereof), and upon
(i) payment to the Company in cash, by certified or official bank check or by
wire transfer for the account of the Company, of the Exercise Price for the
Warrant Shares specified in the Exercise Agreement or (ii) if the holder is
effectuating a Cashless Exercise (as defined in Section 12(c) hereof) pursuant
to Section 12(c) hereof, delivery to the Company of a written notice of an
election to effect a Cashless Exercise for the Warrant Shares specified in the
Exercise Agreement. The Warrant Shares so purchased shall be deemed to be issued
to the holder hereof or such holder's designee, as the record owner of such
shares, as of the close of business on the date on which this Warrant shall have
been surrendered, the completed Exercise Agreement shall have been delivered,
and payment shall have been made for such shares as set forth above or, if such
date is not a business date, on the next succeeding business date. The Warrant
Shares so purchased, representing the aggregate number of shares specified in
the Exercise Agreement, shall be delivered to the holder hereof within a
reasonable time, not exceeding two business days, after this Warrant shall have
been so exercised (the "Delivery Period"). If the Company's transfer agent is
participating in the Depository Trust Company ("DTC") Fast Automated Securities
Transfer program, and so long as the certificates therefor do not bear a legend
and the holder is not obligated to return such certificate for the placement of
a legend thereon, the Company shall cause its transfer agent to electronically
transmit the Warrant Shares so purchased to the holder by crediting the account
of the holder or its nominee with DTC through its Deposit Withdrawal Agent
Commission system ("DTC Transfer"). If the aforementioned conditions to a DTC
Transfer are not satisfied, the Company shall deliver to the holder physical
certificates representing the Warrant Shares so purchased. Further, the holder
may instruct the Company to deliver to the holder physical certificates
representing the Warrant Shares so purchased in lieu of delivering such shares
by way of DTC Transfer. Any certificates so delivered shall be in such
denominations as may be reasonably requested by the holder hereof, shall be
registered in the name of such holder or such other name as shall be designated
by such holder and, following the date on which the Warrant Shares have been
registered under the Securities Act pursuant to that certain Registration Rights
Agreement, dated as of March ___, 2003, by and between the Company and the other
signatories thereto (the "Registration Rights Agreement") or otherwise may be
sold by the holder pursuant to Rule 144 promulgated under the Securities Act (or
a successor rule), shall not bear any restrictive legend. If this Warrant shall
have been exercised only in part, then the Company shall, at its expense, at the
time of delivery of such certificates, deliver to the holder a new Warrant
representing the number of shares with respect to which this Warrant shall not
then have been exercised.

                                       2
<PAGE>

         If, at any time, a holder of this Warrant submits this Warrant, an
Exercise Agreement and payment to the Company of the Exercise Price for each of
the Warrant Shares specified in the Exercise Agreement (including pursuant to a
Cashless Exercise), and the Company fails for any reason (other than the reasons
contemplated by Sections 8(f) and (g) hereof) to deliver, on or prior to the
fourth business day following the expiration of the Delivery Period for such
exercise, the number of shares of Common Stock to which the holder is entitled
upon such exercise (an "EXERCISE DEFAULT"), then the Company shall pay to the
holder payments ("EXERCISE DEFAULT PAYMENTS") for an Exercise Default in the
amount of (a) (N/365), multiplied by (b) the amount by which the Market Price
(as defined herein) on the date the Exercise Agreement giving rise to the
Exercise Default is transmitted in accordance with this Section 1 (the "EXERCISE
DEFAULT DATE") exceeds the Exercise Price in respect of such Warrant Shares,
multiplied by (c) the number of shares of Common Stock the Company failed to so
deliver in such Exercise Default, multiplied by (d) .24, where N equals the
number of days from the Exercise Default Date to the date that the Company
effects the full exercise of this Warrant which gave rise to the Exercise
Default. The accrued Exercise Default Payment for each calendar month shall be
paid in cash or shall be convertible into Common Stock, at the holder's option,
as follows:

         (i) In the event holder elects to take such payment in cash, cash
payment shall be made to the holder by the fifth day of the month following the
month in which it has accrued; and

         (ii) In the event the holder elects to take such payment in Common
Stock, the holder may convert such payment amount into Common Stock at the lower
of the Exercise Price or the Market Price (as in effect at the time of
conversion) at any time after the fifth day of the month following the month in
which it has accrued.

         Nothing herein shall limit the holder's right to pursue actual damages
for the Company's failure to maintain a sufficient number of authorized shares
of Common Stock as required pursuant to the terms of Section 3(b) hereof or to
otherwise issue shares of Common Stock upon exercise of this Warrant in
accordance with the terms hereof, and the holder shall have the right to pursue
all remedies available at law or in equity (including a decree of specific
performance and/or injunctive relief).

         "MARKET PRICE," as of any date, (i) means the closing bid price for the
Common Stock as reported on the OTC Bulletin Board (the "OTC") by Bloomberg
Financial Markets ("BLOOMBERG") or other nationally recognized reporting
service, at the option of the holder hereof, or (ii) if the OTC is not the
principal trading market for the shares of Common Stock, the average of the
reported bid prices reported by Bloomberg or such other nationally recognized
reporting service on the principal trading market for the Common Stock during
the same period, or, if there is no bid price for such period, the last sales
price reported by Bloomberg or such service for such period, or (iii) if the
foregoing do not apply, the last bid price of such security in the
over-the-counter market on the pink sheets for such security as reported by
Bloomberg or such service, or if no bid price is so reported for such security,
the last sale price of such security as reported by Bloomberg or such service,
or (iv) if market value cannot be calculated as of such date on any of the
foregoing bases, the Market Price shall be the average fair market value as
reasonably determined by an investment banking firm selected by the Company and
reasonably

                                       3
<PAGE>

acceptable to the holder, with the costs of the appraisal to be borne by the
Company. The manner of determining the Market Price of the Common Stock set
forth in the foregoing definition shall apply with respect to any other security
in respect of which a determination as to market value must be made hereunder.
For purposes of this Warrant, "TRADING DAY" means any day on which principal
United States securities exchange or trading market where the Common Stock is
then listed or traded, is open for trading.

         2. Period of Exercise. This Warrant is immediately exercisable, at any
time or from time to time on or after November 1, 2003 (the "Exercise Date") and
before 5:00 p.m., New York City time, on the fifth anniversary of the Exercise
Date (the "Exercise Period"), subject to the provisions of Section 5 hereof. The
Exercise Period shall automatically be extended by one (1) day for each day on
which the Company does not have a number of shares of Common Stock reserved for
issuance upon exercise hereof at least equal to the number of shares of Common
Stock issuable upon exercise hereof, or otherwise fails to deliver shares of
Common Stock in the names set forth in Section 1 hereof upon exercise hereof, or
the Warrant Shares are not then otherwise registered for resale pursuant to the
terms of the Registration Rights Agreement.

         3. Certain Agreements of the Company. The Company hereby covenants and
agrees as follows:

         (a) Shares to be Fully Paid. All Warrant Shares will, upon issuance in
accordance with the terms of this Warrant, be validly issued, fully paid, and
nonassessable and free from all taxes, liens, claims and encumbrances.

         (b) Reservation of Shares. During the Exercise Period, the Company
shall at all times have authorized, and reserved for the purpose of issuance
upon exercise of this Warrant, a sufficient number of shares of Common Stock to
provide for the exercise in full of this Warrant (without giving effect to the
limitations on exercise set forth in Section 8(g) hereof).

         (c) Listing. The Company shall promptly secure the listing of the
shares of Common Stock issuable upon exercise of this Warrant upon each national
securities exchange or automated or electronic quotation system, if any, upon
which shares of Common Stock are then listed or become listed (subject to
official notice of issuance upon exercise of this Warrant) and shall maintain,
so long as any other shares of Common Stock shall be so listed, such listing of
all shares of Common Stock from time to time issuable upon the exercise of this
Warrant; and the Company shall so list on each national securities exchange or
automated or electronic quotation system, as the case may be, and shall maintain
such listing of, any other shares of capital stock of the Company issuable upon
the exercise of this Warrant if and so long as any shares of the same class
shall be listed on such national securities exchange or automated or electronic
quotation system.

         (d) Certain Actions Prohibited. The Company will not, by amendment of
its charter or through any reorganization, transfer of assets, consolidation,
merger, dissolution, issue or sale of securities, or any other voluntary action,
avoid or seek to avoid the observance or performance of any of the terms to be
observed or performed by it hereunder, but will at all times in good faith
assist in the carrying out of all the provisions of this Warrant and in the
taking of all such action as may reasonably be requested by the holder of this
Warrant in order to protect the

                                       4
<PAGE>

economic benefit inuring to the holder hereof and the exercise privilege of the
holder of this Warrant against dilution or other impairment, consistent with the
tenor and purpose of this Warrant. Without limiting the generality of the
foregoing, the Company (i) will not increase the par value of any shares of
Common Stock receivable upon the exercise of this Warrant above the Exercise
Price then in effect, and (ii) will take all such actions as may be necessary or
appropriate in order that the Company may validly and legally issue fully paid
and nonassessable shares of Common Stock upon the exercise of this Warrant.

         (e) Successors and Assigns. This Warrant will be binding upon any
entity succeeding to the Company by merger, consolidation, or acquisition of all
or substantially all of the Company's assets.

         (f) Blue Sky Laws. The Company shall, on or before the date of issuance
of any Warrant Shares, take such actions as the Company shall reasonably
determine are necessary to qualify the Warrant Shares for, or obtain exemption
for the Warrant Shares for, sale to the holder of this Warrant upon the exercise
hereof under applicable securities or "blue sky" laws of the states of the
United States, and shall provide evidence of any such action so taken to the
holder of this Warrant prior to such date; provided, however, that the Company
shall not be required in connection therewith or as a condition thereto to (i)
qualify to do business in any jurisdiction where it would not otherwise be
required to qualify but for this Section 3(f), (ii) subject itself to general
taxation in any such jurisdiction or (iii) file a general consent to service of
process in any such jurisdiction.

         4. Antidilution Provisions. From the date hereof and throughout the
Exercise Period, the Exercise Price and the number of Warrant Shares issuable
hereunder shall be subject to adjustment from time to time as provided in this
Section 4. In the event that any adjustment of the Exercise Price as required
herein results in a fraction of a cent, such Exercise Price shall be rounded up
or down to the nearest cent.

         (a) Subdivision or Combination of Common Stock. If the Company, at any
time during the Exercise Period, subdivides (by any stock split, stock dividend,
recapitalization, reorganization, reclassification or otherwise) its shares of
Common Stock into a greater number of shares, then, after the date of record for
effecting such subdivision, the Exercise Price in effect immediately prior to
such subdivision will be proportionately reduced. If the Company, at any time
during the Exercise Period, combines (by reverse stock split, recapitalization,
reorganization, reclassification or otherwise) its shares of Common Stock into a
smaller number of shares, then, after the date of record for effecting such
combination, the Exercise Price in effect immediately prior to such combination
will be proportionately increased.

         (b) Adjustment in Number of Shares. Upon each adjustment of the
Exercise Price pursuant to the provisions of Section 4(a), the number of shares
of Common Stock issuable upon exercise of this Warrant at each such Exercise
Price shall be adjusted by multiplying a number equal to the Exercise Price in
effect immediately prior to such adjustment by the number of shares of Common
Stock issuable upon exercise of this Warrant at such Exercise Price immediately
prior to such adjustment and dividing the product so obtained by the adjusted
Exercise Price.

                                       5
<PAGE>

         (c) Consolidation, Merger or Sale. In case of any consolidation of the
Company with, or merger of the Company into, any other corporation, or in case
of any sale or conveyance of all or substantially all of the assets of the
Company other than in connection with a plan of complete liquidation of the
Company at any time during the Exercise Period, then as a condition of such
consolidation, merger or sale or conveyance, adequate provision will be made
whereby the holder hereof will have the right to acquire and receive upon
exercise of this Warrant in lieu of the shares of Common Stock immediately
theretofore acquirable upon the exercise of this Warrant, such shares of stock,
securities, cash or assets as may be issued or payable with respect to or in
exchange for the number of shares of Common Stock immediately theretofore
acquirable and receivable upon exercise of this Warrant had such consolidation,
merger or sale or conveyance not taken place. In any such case, the Company will
make appropriate provision to insure that the provisions of this Section 4
hereof will thereafter be applicable as nearly as may be in relation to any
shares of stock or securities thereafter deliverable upon the exercise of this
Warrant. The Company will not effect any consolidation, merger or sale or
conveyance unless prior to the consummation thereof, the successor corporation
(if other than the Company) assumes by written instrument the obligations under
this Warrant and the obligations to deliver to the holder hereof such shares of
stock, securities or assets as, in accordance with the foregoing provisions, the
holder may be entitled to acquire. Notwithstanding the foregoing, in the event
of any consolidation of the Company with, or merger of the Company into, any
other corporation, or the sale or conveyance of all or substantially all of the
assets of the Company, at any time during the Exercise Period, where the
consideration consists solely of cash, the holder hereof shall receive, in
connection with such transaction, cash consideration equal to the fair market
value of this Warrant as determined in accordance with customary valuation
methodology used in the investment banking industry.

         (d) Distribution of Assets. In case the Company shall declare or make
any distribution of its assets (or rights to acquire its assets) to holders of
Common Stock as a partial liquidating dividend, stock repurchase by way of
return of capital or otherwise (including any dividend or distribution to the
Company's shareholders of cash or shares (or rights to acquire shares) of
capital stock of a subsidiary) (a "DISTRIBUTION"), at any time during the
Exercise Period, then the holder hereof shall be entitled upon exercise of this
Warrant for the purchase of any or all of the shares of Common Stock subject
hereto, to receive the amount of such assets (or rights) which would have been
payable to the holder had such holder been the holder of such shares of Common
Stock on the record date for the determination of shareholders entitled to such
Distribution. If the Company distributes rights, warrants, options or any other
form of convertible securities and the right to exercise or convert such
securities would expire in accordance with their terms prior to the expiration
of the Exercise Period, then the terms of such securities shall provide that
such exercise or convertibility right shall remain in effect until 30 days after
the date the holder hereof receives such securities pursuant to the exercise
hereof.

         (e) Notice of Adjustment. Upon the occurrence of any event which
requires any adjustment of the Exercise Price, then, and in each such case, the
Company shall give notice thereof to the holder hereof, which notice shall state
the Exercise Price resulting from such adjustment and the increase or decrease
in the number of Warrant Shares purchasable at such

                                       6
<PAGE>

price upon exercise, setting forth in reasonable detail the method of
calculation and the facts upon which such calculation is based. Such calculation
shall be certified by the chief financial officer of the Company.

         (f) No Fractional Shares. No fractional shares of Common Stock are to
be issued upon the exercise of this Warrant, but the Company shall pay a cash
adjustment in respect of any fractional share which would otherwise be issuable
in an amount equal to the same fraction of the Market Price of a share of Common
Stock on the date of such exercise.

         (g) Other Notices. In case at any time:

               (i) the Company shall declare any dividend upon the Common Stock
payable in shares of stock of any class or make any other distribution (other
than dividends or distributions payable in cash out of retained earnings
consistent with the Company's past practices with respect to declaring dividends
and making distributions) to the holders of the Common Stock;

               (ii) the Company shall offer for subscription pro rata to the
holders of the Common Stock any additional shares of stock of any class or other
rights;

               (iii) there shall be any capital reorganization of the Company,
or reclassification of the Common Stock, or consolidation or merger of the
Company with or into, or sale of all or substantially all of its assets to,
another corporation or entity; or

               (iv) there shall be a voluntary or involuntary dissolution,
liquidation or winding up of the Company;

               (v) then, in each such case, the Company shall give to the holder
of this Warrant (A) notice of the date or estimated date on which the books of
the Company shall close or a record shall be taken for determining the holders
of Common Stock entitled to receive any such dividend, distribution, or
subscription rights or for determining the holders of Common Stock entitled to
vote in respect of any such reorganization, reclassification, consolidation,
merger, sale, dissolution, liquidation or winding-up and (B) in the case of any
such reorganization, reclassification, consolidation, merger, sale, dissolution,
liquidation or winding-up, notice of the date (or, if not then known, a
reasonable estimate thereof by the Company) when the same shall take place. Such
notice shall also specify the date on which the holders of Common Stock shall be
entitled to receive such dividend, distribution, or subscription rights or to
exchange their Common Stock for stock or other securities or property
deliverable upon such reorganization, reclassification, consolidation, merger,
sale, dissolution, liquidation, or winding-up, as the case may be. Such notice
shall be given at least thirty (30) days prior to the record date or the date on
which the Company's books are closed in respect thereto. Failure to give any
such notice or any defect therein shall not affect the validity of the
proceedings referred to in clauses (i), (ii), (iii) and (iv) above.
Notwithstanding the foregoing, the Company shall publicly disclose the substance
of any notice delivered hereunder prior to delivery of such notice to the holder
hereof.

                                       7
<PAGE>

         (h) Certain Events. If, at any time during the Exercise Period, any
event occurs of the type contemplated by the adjustment provisions of this
Section 4 but not expressly provided for by such provisions, the Company will
give notice of such event as provided in Section 4(g) hereof, and the Company's
Board of Directors will make an appropriate adjustment in the Exercise Price and
the number of shares of Common Stock acquirable upon exercise of this Warrant at
each such Exercise Price so that the rights of the holder shall be neither
enhanced nor diminished by such event.

5.       Surrender for Cancellation; Mandatory Cancellation.

         (a) If the Company generates Revenues in excess of six million dollars
($6,000,000) (the "Trigger Amount") for the nine month period ended September
30,2003 (the "Nine Month Period"), then the holder(s) hereof shall surrender for
cancellation this Warrant no later than November 1, 2003 (the "Mandatory
Cancellation Date"), subject to extension as described below. "Revenues" shall
mean the gross revenues of the Company determined on a consolidated basis
(except, however, that such calculation shall exclude any revenues derived from
the operations or activities of Level8 ASIA (as that term is defined in the
Securities Purchase Agreement)), and, in all cases, shall be (i) based upon a
determination made, no later than October 31, 2003, at the Company's sole
expense, by the Company's independent public accountants in accordance with
United States generally accepted accounting principles consistently applied, and
(ii) subject to audited independent verification by, and agreement of, the
holder of the Warrant.

         (b) In the event the holder of this Warrant exercises its right to
independently verify the determination made by the Company's independent public
accountants pursuant to subsection (a)(i) of this Section 5 in accordance with
subsection (a)(ii) of this Section 5, the Mandatory Cancellation Date shall be
extended for a period of thirty (30) days (the "Extension Period").

         (c) In the event the Company and the Holder cannot agree, within the
Extension Period, on whether the Company generated the Trigger Amount within the
Nine Month Period, the Company and the Holder hereof shall mutually agree upon
an accounting firm, independent from both the Company and the Holder (the "Third
Party Evaluator"), to evaluate and determine whether the Company generated the
Trigger Amount in the Nine Month Period (the "Third Party Evaluation"). The
determination made by the Third Party Evaluator upon conclusion of the Third
Party Evaluation shall be binding upon the holder of this Warrant and the
Company. The cost of such valuation by the Third Party Evaluator shall be borne
by the Company.

         (d) Notwithstanding anything to the contrary herein, the Warrants shall
not be exercisable, either in whole or in part, during any Extension Period or
during any period during which a Third Party Evaluation is being conducted
pursuant to subsection (c) of this Section 5.

                                       8
<PAGE>

         6. Issue Tax. The issuance of certificates for Warrant Shares upon the
exercise of this Warrant shall be made without charge to the holder of this
Warrant or such shares for any issuance tax or other costs in respect thereof,
provided that the Company shall not be required to pay any tax which may be
payable in respect of any transfer involved in the issuance and delivery of any
certificate in a name other than the holder of this Warrant.

         7. No Rights or Liabilities as a Shareholder. This Warrant shall not
entitle the holder hereof to any voting rights or other rights as a shareholder
of the Company. No provision of this Warrant, in the absence of affirmative
action by the holder hereof to purchase Warrant Shares, and no mere enumeration
herein of the rights or privileges of the holder hereof, shall give rise to any
liability of such holder for the Exercise Price or as a shareholder of the
Company, whether such liability is asserted by the Company or by creditors of
the Company.

         8. Transfer, Exchange, Redemption and Replacement of Warrant.

               (a) Restriction on Transfer. This Warrant and the rights granted
to the holder hereof are transferable, in whole or in part, upon surrender of
this Warrant, together with a properly executed assignment in the form attached
hereto, at the office or agency of the Company referred to in Section 8(e)
below, provided, however, that any transfer or assignment shall be subject to
the conditions set forth in Sections 8(f) and (g) hereof and to the provisions
of Sections 2(f) and 2(g) of the Securities Purchase Agreement. Until due
presentment for registration of transfer on the books of the Company, the
Company may treat the registered holder hereof as the owner and holder hereof
for all purposes, and the Company shall not be affected by any notice to the
contrary. Notwithstanding anything to the contrary contained herein, the
registration rights described in Section 9 hereof are assignable only in
accordance with the provisions of the Registration Rights Agreement.

               (b) Warrant Exchangeable for Different Denominations. This
Warrant is exchangeable, upon the surrender hereof by the holder hereof at the
office or agency of the Company referred to in Section 8(e) below, for new
Warrants of like tenor of different denominations representing in the aggregate
the right to purchase the number of shares of Common Stock which may be
purchased hereunder, each of such new Warrants to represent the right to
purchase such number of shares (at the Exercise Price therefor) as shall be
designated by the holder hereof at the time of such surrender.

               (c) Replacement of Warrant. Upon receipt of evidence reasonably
satisfactory to the Company of the loss, theft, destruction, or mutilation of
this Warrant and, in the case of any such loss, theft, or destruction, upon
delivery of an indemnity agreement reasonably satisfactory in form and amount to
the Company, or, in the case of any such mutilation, upon surrender and
cancellation of this Warrant, the Company, at its expense, will execute and
deliver, in lieu thereof, a new Warrant of like tenor.

               (d) Cancellation; Payment of Expenses. Upon the surrender of this
Warrant in connection with any transfer, exchange, or replacement as provided in
this Section 8, this Warrant shall be promptly canceled by the Company. The
Company shall pay all taxes (other than securities transfer taxes) and all other
expenses (other than legal expenses, if any, incurred by the holder of this
Warrant or transferees) and charges payable in connection with the

                                       9
<PAGE>

preparation, execution, and delivery of Warrants pursuant to this Section 8. The
Company shall indemnify and reimburse the holder of this Warrant for all losses
and damages arising as a result of or related to any breach of the terms of this
Warrant, including costs and expenses (including legal fees) incurred by such
holder in connection with the enforcement of its rights hereunder.

               (e) Warrant Register. The Company shall maintain, at its
principal executive offices (or such other office or agency of the Company as it
may designate by notice to the holder hereof), a register for this Warrant, in
which the Company shall record the name and address of the person in whose name
this Warrant has been issued, as well as the name and address of each transferee
and each prior owner of this Warrant.

               (f) Transfer or Exchange Without Registration. If, at the time of
the surrender of this Warrant in connection with any transfer or exchange of
this Warrant, this Warrant (or, in the case of any exercise, the Warrant Shares
issuable hereunder) shall not be registered under the Securities Act and under
applicable state securities or blue sky laws, the Company may require, as a
condition of allowing such transfer or exchange, (i) that the holder or
transferee of this Warrant, as the case may be, furnish to the Company a written
opinion of counsel (which opinion shall be in form, substance and scope
customary for opinions of counsel in comparable transactions) to the effect that
such transfer or exchange may be made without registration under the Securities
Act and under applicable state securities or blue sky laws (the cost of which
shall be borne by the Company if the Company's counsel renders such an opinion,
and up to $1,000 of such cost shall be borne by the Company if the holder's
counsel is required to render such opinion), (ii) that the holder or transferee
execute and deliver to the Company an investment letter in form and substance
acceptable to the Company and (iii) that the transferee be an "ACCREDITED
INVESTOR" as defined in Rule 501(a) promulgated under the Securities Act;
provided that no such opinion, letter, or status as an "accredited investor"
shall be required in connection with a transfer pursuant to Rule 144 under the
Securities Act.

               (g) Additional Restrictions on Exercise or Transfer. In no event
shall the holder hereof have the right to exercise any portion of this Warrant
for shares of Common Stock or to dispose of any portion of this Warrant to the
extent that such right to effect such exercise or disposition would result in
the holder or any of its affiliates beneficially owning more than 4.99% of the
outstanding shares of Common Stock. For purposes of this Section 8(g),
beneficial ownership shall be determined in accordance with Section 13(d) of the
Securities Exchange Act of 1934, as amended, and Regulation 13D-G thereunder.
The restriction contained in this Section 8(g) may not be altered, amended,
deleted or changed in any manner whatsoever unless the holders of a majority of
the outstanding shares of Common Stock and the holder hereof shall approve, in
writing, such alteration, amendment, deletion or change.

         9. Registration Rights. The initial holder of this Warrant (and certain
assignees thereof) is entitled to the benefit of such registration rights in
respect of the Warrant Shares as are set forth in the Registration Rights
Agreement, including the right to assign such rights to certain assignees, as
set forth therein.

                                       10
<PAGE>

         10. Notices. Any notices required or permitted to be given under the
terms of this Warrant shall be sent by certified or registered mail (return
receipt requested) or delivered personally or by courier or by confirmed
telecopy, and shall be effective five days after being placed in the mail, if
mailed, or upon receipt or refusal of receipt, if delivered personally or by
courier, or by confirmed telecopy, in each case addressed to a party. The
addresses for such communications shall be:

                    If to the Company:

                    Level 8 Systems, Inc.
                    8000 Regency Parkway
                    Cary, North Carolina 27511
                    Facsimile:  (919) 380-5090
                    Attn:  John P. Broderick

                    with a copy simultaneously transmitted by like means to:

                    Powell, Goldstein, Frazer & Murphy LLP
                    191 Peachtree Street; 16th Floor
                    Atlanta, Georgia 30319
                    Facsimile: (404) 572-6999
                    Attn:  Scott D. Smith, Esq.

If to the holder, at such address as such holder shall have provided in writing
to the Company, or at such other address as such holder furnishes by notice
given in accordance with this Section 10, and, if to SDS Merchant Fund, L.P., or
any of its affiliates, with a copy simultaneously transmitted by like means to:

                    Drinker Biddle & Reath LLP One Logan Square 18th &
                    Cherry Streets Philadelphia, PA 19103 U.S.A.
                    Facsimile: (215) 988-2757
                    Attn:  Stephen T. Burdumy, Esq.

         11. Governing Law; Jurisdiction. This Warrant shall be governed by and
construed in accordance with the laws of the State of Delaware. The Company
irrevocably consents to the jurisdiction of the United States federal courts and
state courts located in the County of New Castle, State of Delaware in any suit
or proceeding based on or arising under this Warrant and

                                       11
<PAGE>

irrevocably agrees that all claims in respect of such suit or proceeding may be
determined in such courts. The Company irrevocably waives any objection to the
laying of venue and the defense of an inconvenient forum to the maintenance of
such suit or proceeding. The Company further agrees that service of process upon
the Company mailed by certified or registered mail shall be deemed in every
respect effective service of process upon the Company in any such suit or
proceeding. Nothing herein shall affect the holder's right to serve process in
any other manner permitted by law. The Company agrees that a final
non-appealable judgment in any such suit or proceeding shall be conclusive and
may be enforced in other jurisdictions by suit on such judgment or in any other
lawful manner.

         12. Miscellaneous.

               (a) Amendments. Except as provided in Section 8(g) hereof, this
Warrant and any provision hereof may only be amended by an instrument in writing
signed by the Company and the holder hereof.

               (b) Descriptive Headings. The descriptive headings of the several
Sections of this Warrant are inserted for purposes of reference only, and shall
not affect the meaning or construction of any of the provisions hereof.

               (c) Cashless Exercise. This Warrant may be exercised at any time
during the Exercise Period by presentation and surrender of this Warrant to the
Company at its principal executive offices with a written notice of the holder's
intention to effect a cashless exercise, including a calculation of the number
of shares of Common Stock to be issued upon such exercise in accordance with the
terms hereof (a "CASHLESS EXERCISE"). In the event of a Cashless Exercise, in
lieu of paying the Exercise Price in cash, the holder shall surrender this
Warrant for that number of shares of Common Stock determined by multiplying the
number of Warrant Shares to which it would otherwise be entitled by a fraction,
the numerator of which shall be the difference between the then current Market
Price of a share of the Common Stock on the date of exercise and the Exercise
Price, and the denominator of which shall be the then current Market Price per
share of Common Stock.

               (d) Business Day. For purposes of this Warrant, the term
"BUSINESS DAY" means any day, other than a Saturday or Sunday or a day on which
banking institutions in the State of New York are authorized or obligated by
law, regulation or executive order to close.

                [REMAINDER OF THIS PAGE LEFT BLANK INTENTIONALLY]

                                       12
<PAGE>

         IN WITNESS WHEREOF, the Company has caused this Warrant to be signed by
its duly authorized officer.

                                        LEVEL 8 SYSTEMS, INC.

                                        By:
                                           --------------------------------
                                            John P. Broderick
                                            Chief Financial Officer

<PAGE>

                           FORM OF EXERCISE AGREEMENT

         (TO BE EXECUTED BY THE HOLDER IN ORDER TO EXERCISE THE WARRANT)

         To:
                 Level 8 Systems, Inc.

                 Facsimile:
                 Attn: Chief Executive Officer

         The undersigned hereby irrevocably exercises the right to purchase
_____________ shares of the Common Stock of Level 8 Systems, Inc., a corporation
organized under the laws of the State of Delaware (the "COMPANY"), evidenced by
the attached Warrant, and herewith [makes payment of the Exercise Price with
respect to such shares in full][elects to effect a Cashless Exercise (as defined
in Section 12(c) of such Warrant)], all in accordance with the conditions and
provisions of said Warrant.

         The undersigned agrees not to offer, sell, transfer or otherwise
dispose of any Common Stock obtained on exercise of the Warrant, except under
circumstances that will not result in a violation of the Securities Act of 1933,
as amended, or any state securities laws.

                  |_| The undersigned requests that the Company cause its
                  transfer agent to electronically transmit the Common Stock
                  issuable pursuant to this Exercise Agreement to the account of
                  the undersigned or its nominee (which is _________________)
                  with DTC through its Deposit Withdrawal Agent Commission
                  System ("DTC TRANSFER"), provided that such transfer agent
                  participates in the DTC Fast Automated Securities Transfer
                  program.

                  |_| In lieu of receiving the shares of Common Stock issuable
                  pursuant to this Exercise Agreement by way of DTC Transfer,
                  the undersigned hereby requests that the Company cause its
                  transfer agent to issue and deliver to the undersigned
                  physical certificates representing such shares of Common
                  Stock.

The undersigned requests that a Warrant representing any unexercised portion
hereof be issued, pursuant to the Warrant, in the name of the Holder and
delivered to the undersigned at the address set forth below:

Dated:
      -------------------                 -----------------------------------
                                                 Signature of Holder

                                          -----------------------------------
                                                 Name of Holder (Print)

                                                 Address:

                                          -----------------------------------

                                          -----------------------------------

                                          -----------------------------------

<PAGE>

                               FORM OF ASSIGNMENT

         FOR VALUE RECEIVED, the undersigned hereby sells, assigns, and
transfers all the rights of the undersigned under the within Warrant, with
respect to the number of shares of Common Stock covered thereby set forth
hereinbelow, to:

Name of Assignee          Address                     No. of Shares
----------------          -------                     -------------

, and hereby irrevocably constitutes and appoints ____________________________
as agent and attorney-in-fact to transfer said Warrant on the books of the
within-named corporation, with full power of substitution in the premises.

Dated:                      ,
       ---------------------  ----

In the presence of

----------------------

                                    Name:
                                          --------------------------------------

                                    Signature:
                                               ---------------------------------
                                    Title of Signing Officer or Agent (if any):

                                    Address:
                                            ------------------------------------

                                    Note:    The above signature should
                                             correspond exactly with the name on
                                             the face of the within Warrant.<PAGE>
                                                                            10.1

                          SECURITIES PURCHASE AGREEMENT

      This SECURITIES PURCHASE AGREEMENT (the "AGREEMENT"), dated as of March
29, 2003, is made by and among Level 8 Systems, Inc., a corporation organized
under the laws of the State of Delaware (the "COMPANY"), SDS Merchant Fund,
L.P., a Delaware limited partnership ("SDS"), DMG Legacy Fund LLC, DMG Legacy
Institutional Fund LLC, DMG Legacy International Ltd. (collectively, the DMG
entities shall be known as the "DMG GROUP", and, together with SDS, the "LEAD
INVESTORS") Ike Dweck, an individual, Bruce Miller, an individual, Jim Stevens,
an individual, Fred Mack 4/30/92 Trust, Richard Mack, Vertical Ventures
Investments LLC, Joseph Shelanski, an individual and C. Glen and Joan Dugdale,
individuals (together with the Lead Investors, each, a "PURCHASER" and
collectively, the "PURCHASERS").

WHEREAS:

      A. The Company and the Purchasers are executing and delivering this
Agreement in reliance upon the exemption from securities registration afforded
by the provisions of Regulation D ("REGULATION D"), as promulgated by the United
States Securities and Exchange Commission (the "SEC") under the Securities Act
of 1933, as amended (the "SECURITIES ACT").

      B. Upon the terms and conditions stated in this Agreement, the Company
desires to issue to the Purchasers, and the Purchasers desire to purchase, 3,705
shares of a class of preferred stock of the Company designated as the Company's
Series D Convertible Preferred Stock, par value $.001 per share (the "SERIES D
STOCK"), which such Series D Stock shall be convertible into shares of the
Company's common stock, par value $.001 per share (the "COMMON STOCK"). All
rights and preferences of the Series D Stock shall be as stated in the Company's
Certificate of Designations, Preferences and Rights pertaining to the Series D
Stock (the "CERTIFICATE OF DESIGNATIONS") in the form attached hereto as Exhibit
A. As further inducement for each Purchaser to enter this Agreement, the Company
shall issue two series of warrants to acquire Common Stock, the SERIES D-1
WARRANTS, in the form attached hereto as Exhibit B, and, when issued by the
Company in compliance with the Certificate of Incorporation, the By-laws, and
the laws of the State of Delaware, the SERIES D-2 WARRANTS, in the form attached
hereto as Exhibit C (the Series D-1 Warrants and Series D-2 Warrants are
referenced herein collectively as the "WARRANTS"). The shares of Common Stock
issuable upon conversion of or otherwise pursuant to the Series D Stock are
referred to herein as the "CONVERSION SHARES", and the shares of Common Stock
issuable upon exercise of or otherwise pursuant to the Series D-1 Warrants, and
when the Series D-2 Warrants are issued by the Company in compliance with the
Certificate of Incorporation, the By-laws, and the laws of the State of
Delaware, the shares of Common Stock issuable upon the exercise or otherwise
pursuant to the Series D-2 Warrants, are referred to herein as the "WARRANT
SHARES." The Series D Stock, the Warrants, the Conversion Shares and the Warrant
Shares are collectively referenced herein as the "SECURITIES" and each of them
may individually be referred to herein as a "SECURITY."
<PAGE>
      C. Contemporaneous with the execution and delivery of this Agreement, the
parties hereto are executing and delivering a (i) Registration Rights Agreement,
in the form attached hereto as Exhibit D (the "REGISTRATION RIGHTS AGREEMENT"),
pursuant to which the Company has agreed to provide certain registration rights
under the Securities Act and the rules and regulations promulgated thereunder,
and applicable state securities laws, and (ii) an Escrow Agreement in the form
attached hereto as Exhibit E (the "ESCROW AGREEMENT").

      D. All references herein to monetary denominations shall refer to lawful
money of the United States of America.

      NOW, THEREFORE, in consideration of the premises and mutual covenants
contained herein and other good and valuable consideration, the receipt and
sufficiency of which are hereby acknowledged, the Company and the Purchasers
hereby agree as follows:

         1. PURCHASE AND SALE OF SERIES D STOCK AND WARRANTS.

            (a) Purchase of Series D Stock and Warrants. On the Closing Date (as
defined below), subject to the satisfaction (or waiver) of the conditions set
forth in Section 6 and Section 7 below, the Company shall issue and sell to the
Purchasers, and the Purchasers severally, but not jointly, agree to purchase
from the Company, the number of shares of Series D Stock and Series D-1 Warrants
set forth beside each Purchaser's name in Schedule 1(a), which is attached
hereto and incorporated herein for the price set forth below each Purchaser's
name in Schedule 1(a) (such amount in the aggregate is referenced herein as the
"PURCHASE PRICE"). When the Series D-2 Warrants are issued by the Company in
compliance with the Certificate of Incorporation, the By-laws, and the laws of
the State of Delaware, and provided that such Series D-2 Warrants will be
exercisable in accordance with its terms, the Company will additionally issue to
the Purchasers the Series D-2 Warrants set forth beside each Purchaser's name in
Schedule 1(a).

            (b) Escrow; Payment of Purchase Price. A portion of the Purchase
Price paid by the Lead Investors as set forth in Schedule 1(b) attached hereto
shall be paid at Closing (as defined below) by wire transfer of immediately
available funds to Wachovia Bank, N.A. (the "ESCROW AGENT"), such amount (the
"ESCROW AMOUNT") to be disbursed by the Escrow Agent in the manner described in
the Escrow Agreement.

            (c) Closing Date. Subject to the satisfaction (or waiver) of the
conditions thereto set forth in Section 6 and Section 7 below, the date and time
of the issuance and sale of the Series D Stock and Series D-1 Warrants pursuant
to this Agreement (the "CLOSING") shall be 12:00 noon, New York City time, on
March 29, 2003, or such other time as may be mutually agreed upon by the Company
and the Purchasers (the "CLOSING DATE"). The Closing shall occur at the offices
of Drinker Biddle & Reath LLP, One Logan Squire, 18th and Cherry Streets,
Philadelphia, Pennsylvania 19103, U.S.A.

         2. PURCHASERS' REPRESENTATIONS AND WARRANTIES.

                                      -2-
<PAGE>
      The Purchasers represent and warrant, severally and not jointly, to the
Company as follows:

            (a) Purchase for Own Account, Etc. The Purchasers are purchasing the
Securities for the Purchasers' own account for investment purposes only and not
with a present view towards the public sale or distribution thereof, except
pursuant to sales that are exempt from the registration requirements of the
Securities Act and/or sales registered under the Securities Act. The Purchasers
understand that the Purchasers must bear the economic risk of this investment
indefinitely, unless the Securities are registered pursuant to the Securities
Act and any applicable state securities or blue sky laws or an exemption from
such registration is available, and that the Company has no present intention of
registering the resale of any such Securities other than as contemplated by the
Registration Rights Agreement. Notwithstanding anything in this Section 2(a) to
the contrary, by making the representations herein, the Purchasers do not agree
to hold the Securities for any minimum or other specific term and reserve the
right to dispose of the Securities at any time in accordance with or pursuant to
a registration statement or an exemption from the registration requirements
under the Securities Act.

            (b) Accredited Investor Status. Each Purchaser is an "Accredited
Investor" as that term is defined in Rule 501(a) of Regulation D.

            (c) Reliance on Exemptions. The Purchasers understand that the
Securities are being (and in the case of the Series D-2 Warrants, will be)
offered and sold to the Purchasers in reliance upon specific exemptions from the
registration requirements of United States federal and state securities laws and
that the Company is relying upon the truth and accuracy of, and the Purchasers'
compliance with, the representations, warranties, agreements, acknowledgments
and understandings of the Purchasers set forth herein in order to determine the
availability of such exemptions and the eligibility of the Purchasers to acquire
the Securities.

            (d) Information. The Purchasers and their counsel, if any, have been
furnished all materials relating to the business, finances and operations of the
Company and materials relating to the offer and sale of the Securities which
have been specifically requested by the Purchasers or their counsel. Neither
such inquiries nor any other investigation conducted by the Purchasers or their
counsel or any of their representatives shall modify, amend or affect the
Purchasers' right to rely on the Company's representations and warranties
contained in Section 3 below. The Purchasers understand that the Purchasers'
investment in the Securities involves a high degree of risk.

            (e) Governmental Review. The Purchasers understand that no United
States federal or state agency or any other government or governmental agency
has passed upon or made any recommendation or endorsement of the Securities.

            (f) Transfer or Resale. The Purchasers understand that (i) except as
provided in the Registration Rights Agreement, the sale or resale of the
Securities have not been and are not being registered under the Securities Act
or any state securities laws, and the Securities may not be transferred unless
(A) the resale of the Securities has been registered thereunder; or (B) the
Purchasers shall have delivered to the Company an opinion of counsel

                                      -3-
<PAGE>
(which opinion shall be in form, substance and scope customary for opinions of
counsel in comparable transactions) to the effect that the Securities to be sold
or transferred may be sold or transferred pursuant to an exemption from such
registration; or (C) sold under and in compliance with Rule 144 promulgated
under the Securities Act (or a successor rule) ("RULE 144"); or (D) sold or
transferred to an affiliate of a Purchaser who agrees to sell or otherwise
transfer the Securities only in accordance with the provisions of this Section
2(f) and who is an Accredited Investor; and (ii) neither the Company nor any
other person is under any obligation to register such Securities under the
Securities Act or any state securities laws (other than pursuant to the terms of
the Registration Rights Agreement). Notwithstanding the foregoing or anything
else contained herein to the contrary, the Securities may be pledged as
collateral in connection with a bona fide margin account or other lending
arrangement, provided such pledge is consistent with applicable laws, rules and
regulations.

            (g) Legends. The Purchasers understand that the Series D Stock and
Warrants and, until such time as the Conversion Shares and Warrant Shares have
been registered under the Securities Act (including registration pursuant to
Rule 416 thereunder) as contemplated by the Registration Rights Agreement or
otherwise may be sold by the Purchasers under Rule 144, the certificates for the
Conversion Shares and Warrant Shares may bear a restrictive legend in
substantially the following form:

            The securities represented by this certificate have not been
      registered under the Securities Act of 1933, as amended, or the securities
      laws of any state of the United States or in any other jurisdiction. The
      securities represented hereby may not be offered, sold or transferred in
      the absence of an effective registration statement for the securities
      under applicable securities laws unless offered, sold or transferred
      pursuant to an available exemption from the registration requirements of
      those laws.

      The Company agrees that it shall, immediately following the Registration
Statement (as defined in the Registration Rights Agreement) being declared
effective, deliver to its transfer agent an opinion letter of counsel, opining
that at any time the Registration Statement is effective, the transfer agent
shall issue, in connection with the issuance of the Conversion Shares and
Warrant Shares, certificates representing such Conversion Shares and Warrant
Shares without the restrictive legend above (provided such Conversion Shares and
Warrant Shares are to be sold pursuant to the prospectus contained in the
Registration Statement). Upon receipt of such opinion, the Company shall cause
the transfer agent to confirm, for the benefit of the holders, that no further
opinion of counsel is required at the time of transfer in order to issue such
shares without such restrictive legend.

      The legend set forth above shall be removed and the Company shall issue a
certificate without such legend to the holder of any Security upon which it is
stamped, if, unless otherwise required by state securities laws, (i) the sale of
such Security is registered under the Securities Act (including registration
pursuant to Rule 416 thereunder) as contemplated by the Registration Rights
Agreement; (ii) such holder provides the Company with an opinion of counsel, in
form, substance and scope customary for opinions of counsel in comparable
transactions, to the effect that a public sale or transfer of such Security may
be made without registration under the

                                      -4-
<PAGE>
Securities Act; or (iii) such holder provides the Company with reasonable
assurances that such Security can be sold under Rule 144. In the event the above
legend is removed from any Security and thereafter the effectiveness of a
registration statement covering such Security is suspended or the Company
determines that a supplement or amendment thereto is required by applicable
securities laws, then upon reasonable advance written notice to the Purchasers
the Company may require that the above legend be placed on any such Security
that cannot then be sold pursuant to an effective registration statement or
under Rule 144 and the Purchasers shall cooperate in the replacement of such
legend. Such legend shall thereafter be removed when such Security may again be
sold pursuant to an effective registration statement or under Rule 144.

            (h) Authorization; Enforcement. This Agreement and the Registration
Rights Agreement have been duly and validly authorized, executed and delivered
on behalf of the Purchasers and are valid and binding agreements of the
Purchasers enforceable against the Purchasers in accordance with their terms.

            (i) Residency. Each Purchaser is a resident of the jurisdiction set
forth beside such Purchaser's name on Schedule 1(a) attached hereto.

            (j) Limitations. Except as set forth in Section 2(h) hereof, the
Purchasers' representations and warranties made in this Article 2 are made
solely for the purpose of permitting the Company to make a determination that
the offer and sale of the Series D Stock and Warrants pursuant to this Agreement
comply with applicable U.S. federal and state securities laws and not for any
other purpose. Accordingly, the Company should not rely on such representations
and warranties for any other purpose.

         3. REPRESENTATIONS AND WARRANTIES OF THE COMPANY.

      The Company represents and warrants to the Purchasers as follows:

            (a) Organization and Qualification. The Company and each of its
principal subsidiaries, Cicero Technologies, Inc. and Level 8 Technologies, Inc.
(collectively, the "Principal Subsidiaries"), is a corporation duly organized
and existing and in good standing under the laws of the jurisdiction in which it
is incorporated, and has the requisite corporate power to own its properties and
to carry on its business as now being conducted. The Company and each of its
Principal Subsidiaries is duly qualified as a foreign corporation to do business
and is in good standing in every jurisdiction in which the nature of the
business conducted by it makes such qualification necessary and where the
failure so to qualify would have a Material Adverse Effect. "MATERIAL ADVERSE
EFFECT" means any material adverse effect on (i) the Securities, (ii) the
ability of the Company to perform its obligations hereunder or under the Series
D Stock, the Warrants or the Registration Rights Agreement or (iii) the
business, operations, properties, prospects, financial condition or results of
operations of the Company and its Principal Subsidiaries, taken as a whole.

            (b) Authorization; Enforcement. (i) The Company has the requisite
corporate power and authority to enter into and perform its obligations under
this Agreement, the Certificate of Designations, the Series D-1 Warrants, the
Registration Rights Agreement, the

                                      -5-
<PAGE>
Escrow Agreement, and when the Series D-2 Warrants are issued by the Company in
compliance with the Certificate of Incorporation, the By-laws, and the laws of
the State of Delaware, the Series D-2 Warrants (the "TRANSACTION DOCUMENTS") to
issue and sell the Series D Stock and the Series D-1 Warrants, and when the
Series D-2 Warrants are issued by the Company in compliance with the Certificate
of Incorporation, the By-laws, and the laws of the State of Delaware, the Series
D-2 Warrants, in accordance with the terms hereof, to issue the Conversion
Shares upon conversion of the Series D Stock in accordance with the terms
thereof, to issue the Warrant Shares underlying the Series D-1 Warrants upon
exercise of the Series D-1 Warrants in accordance with the terms thereof, and
when the Series D-2 Warrants are issued by the Company in compliance with the
Certificate of Incorporation, the By-laws, and the laws of the State of
Delaware, to issue the Warrant Shares underlying the Series D-2 Warrants upon
exercise of the Series D-2 Warrants in accordance with the terms thereof; (ii)
the execution, delivery and performance of this Agreement and the other
Transaction Documents by the Company and the consummation by it of the
transactions contemplated hereby and thereby (including, without limitation, the
issuance of the Series D Stock and the Series D-1 Warrants and the issuance and
reservation for issuance of the Conversion Shares and Warrant Shares underlying
the Series D-1 Warrants, and when the Series D-2 Warrants are issued by the
Company in compliance with the Certificate of Incorporation, the By-laws, and
the laws of the State of Delaware, the issuance of the Series D-2 Warrants and
the issuance and reservation of the Warrant Shares underlying the Series D-2
Warrants) have been duly authorized by the Company's Board of Directors and no
further consent or authorization of the Company, its Board of Directors, or any
committee of the Board of Directors is required, and (iii) this Agreement
constitutes, and, upon execution and delivery by the Company of the Registration
Rights Agreement, the Warrants and the Escrow Agreement, such agreements will
constitute, valid and binding obligations of the Company enforceable against the
Company in accordance with their terms, except that rights to indemnification
and contribution may be limited by Federal or state securities laws or public
policy relating thereto.

            (c) Stockholder Authorization. Except with respect to the issuance
of the Series D-2 Warrants and the Warrant Shares underlying the Series D-2
Warrants, neither the execution, delivery or performance by the Company of its
obligations under this Agreement or the other Transaction Documents, nor the
consummation by it of the transactions contemplated hereby or thereby
(including, without limitation, the issuance of the Series D Stock or the Series
D-1 Warrants or the issuance or reservation for issuance of the Conversion
Shares or Warrant Shares underlying the Series D-1 Warrants) requires any
consent or authorization of the Company's stockholders.

            (d) Capitalization. The capitalization of the Company as of the date
hereof, including the authorized capital stock, the number of shares issued and
outstanding, the number of shares issuable and reserved for issuance pursuant to
the Company's stock option plans, the number of shares issuable and reserved for
issuance pursuant to securities (other than the Series D Stock and the Warrants)
exercisable or exchangeable for, or convertible into, any shares of capital
stock and the number of shares to be reserved for issuance upon conversion of
the Series D Stock and exercise of the Series D-1 Warrants is set forth on
Schedule 3(d). All of such outstanding shares of capital stock have been, or
upon issuance, will be, validly issued, fully paid and non-assessable. Except as
set forth on Schedule 3(d), no shares of capital stock of

                                      -6-
<PAGE>
the Company (including the Conversion Shares and the Warrant Shares underlying
the Series D-1 Warrants) are, or in the case of the Warrant Shares underlying
the Series D-2 Warrants will be, subject to preemptive rights or any other
similar rights of the stockholders of the Company or any liens or encumbrances.
Except for the Securities and as set forth on Schedule 3(d), as of the date of
this Agreement, (i) there are no outstanding options, warrants, scrip, rights to
subscribe to, calls or commitments of any character whatsoever relating to, or
securities or rights convertible into or exercisable or exchangeable for, any
shares of capital stock of the Company or any of its subsidiaries, or
arrangements by which the Company or any of its subsidiaries is or may become
bound to issue additional shares of capital stock of the Company or any of its
Principal Subsidiaries, nor are any such issuances or arrangements contemplated,
and (ii) there are no agreements or arrangements under which the Company or any
of its Principal Subsidiaries is obligated to register the sale of any of its or
their securities under the Securities Act (except the Registration Rights
Agreement). Schedule 3(d) sets forth all of the securities or instruments issued
by the Company or any of its Principal Subsidiaries that contain antidilution or
similar provisions that will be triggered by, and all of the resulting
adjustments that will be made to such securities and instruments as a result of,
the issuance of the Securities in accordance with the terms of this Agreement,
the Series D Stock or the Warrants. The Company has furnished to the Purchasers
true and correct copies of the Company's Certificate of Incorporation as in
effect on the date hereof ("CERTIFICATE OF INCORPORATION"), the Company's
By-laws as in effect on the date hereof (the "BY-LAWS"), and all other
instruments and agreements governing securities convertible into or exercisable
or exchangeable for capital stock of the Company.

            (e) Issuance of Shares. The Conversion Shares and the Warrant Shares
underlying the Series D-1 Warrants are duly authorized and reserved for
issuance, and, upon conversion of the Series D Stock and exercise of the Series
D-1 Warrants in accordance with the terms thereof, will be validly issued, fully
paid and non-assessable, and free from all taxes, liens, claims and encumbrances
and, except as set forth in Schedule 3(d), will not be subject to preemptive
rights, rights of first refusal or other similar rights of stockholders of the
Company and will not impose personal liability upon the holder thereof. When the
Series D-2 Warrants are issued by the Company in compliance with the Certificate
of Incorporation, the Bylaws, and the laws of the State of Delaware, the Warrant
Shares underlying the Series D-2 Warrants will be duly authorized and reserved
for issuance, and, upon exercise of the Series D-2 Warrants in accordance with
the terms thereof, will be validly issued, fully paid and non-assessable, and
free from all taxes, liens, claims and encumbrances and, except as set forth in
Schedule 3(d), will not be subject to preemptive rights, rights of first refusal
or other similar rights of stockholders of the Company and will not impose
personal liability upon the holder thereof.

            (f) No Conflicts. The (A) execution, delivery and performance of
this Agreement, the Registration Rights Agreement, the Series D Stock, and the
Series D-1 Warrants, and when the Series D-2 Warrants are issued by the Company
in compliance with the Certificate of Incorporation, the By-laws, and the laws
of the State of Delaware, the Series D-2 Warrants, by the Company, and (B)
consummation by the Company of the transactions contemplated hereby and thereby
(including, without limitation, the issuance and reservation for issuance, as
applicable, of the Series D Stock, the Series D-1 Warrants, the Conversion
Shares and Warrant Shares underlying the Series D-1 Warrants, and when the
Series D-2 Warrants are issued by the

                                      -7-
<PAGE>
Company in compliance with the Certificate of Incorporation, the By-laws, and
the laws of the State of Delaware, the Series D-2 Warrants and the Warrant
Shares underlying the Series D-2 Warrants) will not (i) result in a violation of
the Certificate of Incorporation or By-laws or (ii) conflict with, or constitute
a default (or an event that with notice or lapse of time or both would become a
default) under, or give to others any rights of termination, amendment
(including, without limitation, the triggering of any anti-dilution provisions),
acceleration or cancellation of, any agreement, indenture or instrument to which
the Company or any of its subsidiaries is a party, or result in a violation of
any law, rule, regulation, order, judgment or decree (including United States
federal and state securities laws and regulations and rules or regulations of
any self-regulatory organizations to which either the Company or its securities
are subject) applicable to the Company or any of its Principal Subsidiaries or
by which any property or asset of the Company or any of its subsidiaries is
bound or affected (except, with respect to clause (ii), for such conflicts,
defaults, terminations, amendments, accelerations, cancellations and violations
that would not, individually or in the aggregate, have a Material Adverse
Effect). Neither the Company nor any of its Principal Subsidiaries is in
violation of its Certificate of Incorporation, By-laws or other organizational
documents and neither the Company nor any of its Principal Subsidiaries is in
default (and no event has occurred which, with notice or lapse of time or both,
would put the Company or any of its Principal Subsidiaries in default) under,
nor has there occurred any event giving others (with notice or lapse of time or
both) any rights of termination, amendment, acceleration or cancellation of, any
agreement, indenture or instrument to which the Company or any of its Principal
Subsidiaries is a party, except for actual or possible violations, defaults or
rights that would not, individually or in the aggregate, have a Material Adverse
Effect. The businesses of the Company and its Principal Subsidiaries are not
being conducted, and shall not be conducted so long as the Purchasers own any of
the Securities, in violation of any law, ordinance or regulation of any
governmental entity, except for possible violations the sanctions for which
either singly or in the aggregate would not have a Material Adverse Effect. The
Company and its board of directors have taken all necessary action, if any, in
order to render inapplicable any control share acquisition, business
combination, poison pill (including any distribution under a rights agreement)
or other similar anti-takeover provision under its Certificate of Incorporation
or the laws of the state of its incorporation which is or could become
applicable to the Purchasers as a result of the transactions contemplated by
this Agreement, including without limitation, the Company's issuance of the
Securities and any and all Purchaser's ownership of the Securities or the
Purchaser's ownership of the Common Stock. Except as specifically contemplated
by this Agreement and the Registration Rights Agreement, the Company is not
required to obtain any consent, approval, authorization or order of, or make any
filing or registration with, any court or governmental agency or any regulatory
or self regulatory agency or other third party in order for it to execute,
deliver or perform any of its obligations under this Agreement or any of the
other Transaction Documents, in each case in accordance with the terms hereof or
thereof. The Common Stock is eligible for trading on the OTC Bulletin Board
("OTC") and the Company does not reasonably anticipate that the Common Stock
will be ineligible for trading on the OTC for the foreseeable future.

            (g) SEC Documents, Financial Statements. Except as set forth on
Schedule 3(g), since December 31, 1997, the Company has timely filed (within
applicable extension periods) all reports, schedules, forms, statements and
other documents required to be filed by it with the SEC pursuant to the
reporting requirements of Sections 13, 14 and 15(d) of

                                      -8-
<PAGE>
the Securities Exchange Act of 1934, as amended (the "EXCHANGE ACT") (all of the
foregoing filed prior to the date hereof and all exhibits included therein and
financial statements and schedules thereto and documents incorporated by
reference therein, being hereinafter referred to herein as the "SEC DOCUMENTS").
As of their respective dates, the SEC Documents complied in all material
respects with the requirements of the Exchange Act or the Securities Act, as the
case may be, and the rules and regulations of the SEC promulgated thereunder
applicable to the SEC Documents, and none of the SEC Documents, at the time they
were filed with the SEC, contained any untrue statement of a material fact or
omitted to state a material fact required to be stated therein or necessary in
order to make the statements therein, in light of the circumstances under which
they were made, not misleading. None of the statements made in any such SEC
Documents is, or has been, required to be amended or updated under applicable
law (except for such statements as have been amended or updated in subsequent
filings made prior to the date hereof). As of their respective dates, the
financial statements of the Company included in the SEC Documents complied as to
form in all material respects with applicable accounting requirements and the
published rules and regulations of the SEC applicable with respect thereto. Such
financial statements have been prepared in accordance with U.S. generally
accepted accounting principles ("GAAP"), consistently applied, during the
periods involved (except (i) as may be otherwise indicated in such financial
statements or the notes thereto, or (ii) in the case of unaudited interim
statements, to the extent they may not include footnotes or may be condensed or
summary statements) and fairly present in all material respects the consolidated
financial position of the Company and its consolidated subsidiaries as of the
dates thereof and the consolidated results of their operations and cash flows
for the periods then ended (subject, in the case of unaudited statements, to
immaterial year-end audit adjustments). Except as set forth in the financial
statements of the Company included in the SEC Documents filed prior to the date
hereof, the Company has no liabilities, contingent or otherwise, other than (i)
liabilities incurred in the ordinary course of business subsequent to the date
of such financial statements and (ii) obligations under contracts and
commitments incurred in the ordinary course of business and not required under
GAAP to be reflected in such financial statements, which liabilities and
obligations referred to in clauses (i) and (ii), individually or in the
aggregate, are not material to the financial condition or operating results of
the Company.

            (h) Absence of Certain Changes. Since September 30, 2002, there has
been no material adverse change and no material adverse development in the
business, properties, operations, prospects, financial condition or results of
operations of the Company and its Principal Subsidiaries, taken as a whole,
except as disclosed in the SEC Documents filed prior to the date hereof. The
Company has not taken any steps, and does not currently expect to take any
steps, to seek protection pursuant to any bankruptcy or receivership law nor
does the Company or any of its Principal Subsidiaries have any knowledge or
reason to believe that its creditors intend to initiate involuntary bankruptcy
proceedings with respect to the Company or any of its Principal Subsidiaries.

            (i) Transactions With Affiliates. Except as set forth in the SEC
Documents filed prior to the date hereof, and other than the grant of stock
options pursuant to option plans disclosed in such SEC Documents, none of the
officers, directors, or employees of the Company is presently a party to any
transaction with the Company or any of its Principal Subsidiaries (other than
for ordinary course services solely in their capacity as employees,

                                      -9-
<PAGE>
officers or directors), including any contract, agreement or other arrangement
providing for the furnishing of services to or by, providing for rental of real
or personal property to or from, or otherwise requiring payments to or from any
such officer, director or employee or any corporation, partnership, trust or
other entity in which any such officer, director, or employee has an ownership
interest of five percent or more or is an officer, director, trustee or partner.

            (j) Absence of Litigation. Except as disclosed in the SEC Documents
filed prior to the date hereof, there is no action, suit, proceeding, inquiry or
investigation before or by any court, public board, government agency,
self-regulatory organization or body, including, without limitation, the SEC,
pending or, to the best knowledge of the Company or any of its Principal
Subsidiaries, threatened against or affecting the Company, any of its Principal
Subsidiaries, or any of their respective directors or officers in their
capacities as such. To the Company's knowledge, there are no facts which, if
known by a potential claimant or governmental authority, could give rise to a
claim or proceeding which, if asserted or conducted with results unfavorable to
the Company or any of its Principal Subsidiaries could reasonably be expected to
have a Material Adverse Effect.

            (k) Intellectual Property. Each of the Company and its Principal
Subsidiaries owns or is licensed (and, in such event, has the right to grant
sublicenses) to use all patents, patent applications, trademarks, trademark
applications, trade names, service marks, copyrights, copyright applications,
licenses, permits, inventions, discoveries, processes, scientific, technical,
engineering and marketing data, object and source codes, know-how (including
trade secrets and other unpatented and/or unpatentable proprietary or
confidential information, systems or procedures) and other similar rights and
proprietary knowledge necessary for the conduct of its business as now being
conducted, or presently contemplated to be conducted in the future
(collectively, "INTANGIBLES"). Schedule 3(k) to this Agreement sets forth a list
of all state and federally registered Intangibles owned and/or used by the
Company in its business including, without limitation, the Intangibles to be
licensed by the Company to an entity to be created as a joint venture with the
Lead Investors presently contemplated to be formed in Mauritius, or any
affiliate or successor thereof. Neither the Company nor any of its Principal
Subsidiaries infringes or is in conflict with any right of any other person with
respect to any third party Intangibles which, if the subject of an unfavorable
decision, ruling or finding, would have a Material Adverse Effect. Neither the
Company nor any of its Principal Subsidiaries has received written notice of any
pending conflict with or infringement upon such third party Intangibles. Neither
the Company nor any of its Principal Subsidiaries has entered into any consent
agreement, indemnification agreement, forbearance to sue or settlement agreement
with respect to the validity of the Company's or its Principal Subsidiaries'
ownership or right to use its Intangibles and, to the Company's knowledge, there
is no reasonable basis for any such claim to be successful. The Intangibles set
forth on Schedule 3(k) are valid and enforceable and no registration relating
thereto has lapsed, expired or been abandoned or canceled or is the subject of
cancellation or other adversarial proceedings, and all applications therefor are
pending and in good standing. The Company and its Principal Subsidiaries have
complied, in all material respects, with their respective contractual
obligations relating to the protection of the Intangibles used pursuant to
licenses. To the Company's knowledge, no person is infringing on or violating
the Intangibles owned or used by the Company or its Principal Subsidiaries.

                                      -10-
<PAGE>
            (l) Foreign Corrupt Practices. Neither the Company, nor any of its
Principal Subsidiaries, nor any director, officer, agent, employee or other
person acting on behalf of the Company or any of its Principal Subsidiaries has,
in the course of his actions for, or on behalf of, the Company, used any
corporate funds for any unlawful contribution, gift, entertainment or other
unlawful expenses relating to political activity, made any direct or indirect
unlawful payment to any foreign or domestic government official or employee from
corporate funds, violated or is in violation of any provision of the U.S.
Foreign Corrupt Practices Act of 1977, or made any bribe, rebate, payoff,
influence payment, kickback or other unlawful payment to any foreign or domestic
government official or employee.

            (m) Disclosure. All information relating to or concerning the
Company and/or any of its Principal Subsidiaries set forth in this Agreement or
provided to the Purchasers pursuant to Section 2(d) hereof or otherwise in
connection with the transactions contemplated hereby and the schedules hereto is
true and correct in all material respects and the Company has not omitted to
state any material fact necessary in order to make the statements made herein or
therein, in light of the circumstances under which they were made, not
misleading. To the Company's knowledge, no event or circumstance has occurred or
exists with respect to the Company or its Principal Subsidiaries or their
respective businesses, properties, prospects, operations or financial conditions
(except for those outside the control of the Company or its Principal
Subsidiaries) which has not been publicly disclosed but, under applicable law,
rule or regulation, would be required to be disclosed by the Company in a
registration statement filed on the date hereof by the Company under the
Securities Act with respect to a primary issuance of the Company's securities.

            (n) Acknowledgment Regarding Purchasers' Purchase of the Securities.
The Company acknowledges and agrees that each Purchaser is acting solely in the
capacity of arm's length purchaser with respect to the Transaction Documents and
the transactions contemplated hereby and thereby, and that no Purchaser is (i)
an officer or director of the Company, (ii) an "affiliate" of the Company (as
defined in Rule 144) or (iii) a "beneficial owner" of more than 5% of the Common
Stock (as defined for purposes of Rule 13d-3 of the Exchange Act). The Company
further acknowledges that no Purchaser is acting as a financial advisor or
fiduciary of the Company (or in any similar capacity) with respect to the
Transaction Documents and the transactions contemplated hereby and thereby, and
any advice given by a Purchaser or any of its representatives or agents in
connection with the Transaction Documents and the transactions contemplated
hereby and thereby is merely incidental to such Purchaser's purchase of the
Securities. The Company further represents to each Purchaser that the Company's
decision to enter into the Transaction Documents has been based solely on the
independent evaluation by the Company and its representatives.

            (o) Listing. The Company has secured the listing of the Conversion
Shares and Warrant Shares underlying the Series D-1 Warrants upon each national
securities exchange, automated quotation system or over-the-counter market upon
which shares of Common Stock are currently listed (subject to official notice of
issuance). When the Series D-2 Warrants are issued by the Company in compliance
with the Certificate of Incorporation, the By-laws, and the laws of the State of
Delaware, the Company will secure the listing of the Warrant Shares underlying
the Series D-2 Warrants upon each national securities exchange, automated

                                      -11-
<PAGE>
quotation system or over-the-counter market upon which shares of Common Stock
are currently listed (subject to official notice of issuance).

            (p) Resale Registration Eligibility. The Company is eligible to
register the resale of its Common Stock on a registration statement under the
Securities Act. There exist no facts or circumstances that would prohibit or
delay the preparation and filing of a registration statement with respect to the
Registrable Securities (as defined in the Registration Rights Agreement). The
Company has no basis to believe that its past or present independent public
auditors will withhold their consent to the inclusion, or incorporation by
reference, of their audit opinion concerning the Company's financial statements
which are included in the Registration Statement required to be filed pursuant
to the Registration Rights Agreement.

            (q) No General Solicitation. Neither the Company nor any distributor
participating on the Company's behalf in the transactions contemplated hereby
(if any) nor any person acting for the Company, or any such distributor, has
conducted any "general solicitation," as such term is defined in Regulation D,
with respect to any of the Securities being offered hereby.

            (r) No Integrated Offering. Neither the Company, nor any of its
affiliates, nor any person acting on its or their behalf, has directly or
indirectly made any offers or sales of any security or solicited any offers to
buy any security under circumstances that would require registration of the
Securities being offered hereby under the Securities Act or cause this offering
of Securities to be integrated with any prior offering of securities of the
Company for purposes of the Securities Act, which result of such integration
would require registration under the Securities Act, or any applicable
stockholder approval provisions.

            (s) No Brokers. Except as set forth on Schedule 3(s), the Company
has taken no action that would give rise to any claim by any person for
brokerage commissions, finder's fees or similar payments by any Purchaser
relating to this Agreement or the transactions contemplated hereby.

            (t) Acknowledgment Regarding Securities. The Company's executive
officers have studied and fully understand the nature of the Securities being
sold hereunder. The Company acknowledges that its obligations to issue
Conversion Shares upon conversion of the Series D Stock in accordance with the
terms of the Certificate of Designations and the Warrant Shares upon the
exercise of the Warrants are (or in the case of the Series D-2 Warrants, will
be) absolute and unconditional, regardless of the dilution that such issuance
may have on the ownership interests of other stockholders. Taking the foregoing
into account, the Company's Board of Directors has determined in its good faith
business judgment that the issuance of the Series D Stock and Series D-1
Warrants hereunder and the consummation of the other transactions contemplated
hereby are in the best interests of the Company and its stockholders.

            (u) Title. The Company and its Principal Subsidiaries have good and
marketable title in fee simple to all real property and good and merchantable
title to all personal property owned by them that is material to the business of
the Company and its Principal Subsidiaries, in each case free and clear of all
liens, encumbrances and defects except such as do

                                      -12-
<PAGE>
not materially affect the value of such property and do not materially interfere
with the use made and proposed to be made of such property by the Company and
its Principal Subsidiaries. Any real property and facilities held under lease by
the Company and its Principal Subsidiaries are held by them under valid,
subsisting and enforceable leases with such exceptions as are not material and
do not materially interfere with the use made and proposed to be made of such
property and buildings by the Company and its Principal Subsidiaries.

            (v) Tax Status. Except as set forth in the SEC Documents, the
Company and each of its Principal Subsidiaries has made or filed all foreign,
U.S. federal, state, provincial and local income and all other tax returns,
reports and declarations required by any jurisdiction to which it is subject
(unless and only to the extent that the Company and each of its Principal
Subsidiaries has set aside on its books provisions reasonably adequate for the
payment of all unpaid and unreported taxes) and has paid all taxes and other
governmental assessments and charges that are material in amount, shown or
determined to be due on such returns, reports and declarations, except those
being contested in good faith and has set aside on its books provisions
reasonably adequate for the payment of all taxes for periods subsequent to the
periods to which such returns, reports or declarations apply. There are no
unpaid taxes in any material amount claimed to be due by the taxing authority of
any jurisdiction, and the officers of the Company know of no basis for any such
claim. The Company has not executed a waiver with respect to any statute of
limitations relating to the assessment or collection of any foreign, federal,
state, provincial or local tax. None of the Company's tax returns is presently
being audited by any taxing authority.

            (w) Key Employees. Each of the Company's directors and officers and
any Key Employee (as defined below) is currently serving the Company in the
capacity disclosed in the SEC Documents. To the Company's knowledge, no Key
Employee is, or is now expected to be, in violation of any material term of any
employment contract, confidentiality, disclosure or proprietary information
agreement, non-competition agreement, or any other contract or agreement or any
restrictive covenant, and the continued employment of each Key Employee does not
subject the Company or any of its Principal Subsidiaries to any material
liability with respect to any of the foregoing matters. No Key Employee has, to
the Company's knowledge, any intention to terminate or limit his employment
with, or services to, the Company or any of its Principal Subsidiaries, nor, to
the knowledge of the Company, is any such Key Employee subject to any
constraints which would cause such employee to be unable to devote his full time
and attention to such employment or services. "KEY EMPLOYEE" means the persons
listed on Schedule 3(w).

            (x) Employee Relations. (i) Neither the Company nor any of its
Principal Subsidiaries is involved in any material union labor dispute nor, to
the knowledge of the Company or any of its Principal Subsidiaries, is any such
dispute threatened. The Company and its Principal Subsidiaries believe that
their relations with their employees are good. No executive officer (as defined
in Rule 501(f) of the 1933 Act) has notified the Company that such officer
intends to leave the Company or otherwise terminate such officer's employment
with the Company; and (ii) the Company and its Principal Subsidiaries are in
compliance with all federal, state, local and foreign laws and regulations
respecting employment and employment practices, terms and conditions of
employment and wages and hours, except where failure to be in

                                      -13-
<PAGE>
compliance would not, either individually or in the aggregate, reasonably be
expected to result in a Material Adverse Effect.

            (y) Insurance. The Company and each of its Principal Subsidiaries
has in force fire, casualty, product liability and other insurance policies,
with extended coverage, sufficient in amount to allow it to replace any of its
material properties or assets which might be damaged or destroyed or sufficient
to cover liabilities to which the Company may reasonably become subject, and
such types and amounts of other insurance with respect to its business and
properties, on both a per occurrence and an aggregate basis, as are customarily
carried by persons engaged in the same or similar business as the Company. No
default or event has occurred that could give rise to a default under any such
policy.

            (z) Environmental Matters. There is no environmental litigation or
other environmental proceeding pending or threatened by any governmental
regulatory authority or others with respect to the current or any former
business of the Company or any of its Principal Subsidiaries or any partnership
or joint venture currently or at any time affiliated with the Company or any of
its Principal Subsidiaries. No state of facts exists as to environmental matters
or Hazardous Substances (as defined below) that involves the reasonable
likelihood of a material capital expenditure by the Company or any of its
Principal Subsidiaries that may otherwise have a Material Adverse Effect. No
Hazardous Substances have been treated, stored or disposed of, or otherwise
deposited, in or on the properties owned or leased by the Company or any of its
subsidiaries or by any partnership or joint venture currently or at any time
affiliated with the Company in violation of any applicable environmental laws.
The environmental compliance programs of the Company and each of its Principal
Subsidiaries comply in all respects with all environmental laws, whether
foreign, federal, state, provincial or local, currently in effect. As used
herein, "HAZARDOUS SUBSTANCES" means any substance, waste, contaminant,
pollutant or material that has been determined by any governmental authority to
be capable of posing a risk of injury to health, safety, property or the
environment.

            (aa) Regulatory Permits. The Company and each of its Principal
Subsidiaries possess all certificates, authorizations and permits issued by the
appropriate federal, state, provincial or foreign regulatory authorities which
are material to the conduct to its business, and neither the Company nor any of
its Principal Subsidiaries has received any notice of proceeding relating to the
revocation or modification of any such certificate, authorization or permit.

            (bb) Subsidiary Rights. The Company or one of its Principal
Subsidiaries has the unrestricted right to vote, and (subject to limitations
imposed by applicable law) to receive dividends and distributions on, all
capital securities of its Principal Subsidiaries as owned by the Company or any
of its Principal Subsidiaries.

            (cc) Subsidiaries other than the Principal Subsidiaries. Schedule
3(cc) identifies each of the Company's subsidiaries other than the Principal
Subsidiaries (the subsidiaries identified on Schedule 3(cc) shall be referenced
herein as the "Inactive Subsidiaries"). The Inactive Subsidiaries, individually
and collectively, have no material business operations or assets.

                                      -14-
<PAGE>
            (dd) Series A3 and Series B3 Warrants. Schedule 3(dd) identifies (i)
each of the holders of warrants to purchase Common Stock that were issued by the
Company in connection with the Company's issuance of Series A3 Convertible
Redeemable Preferred Stock of the Company (having the rights and preferences as
set forth in that certain Certificate of Designation of Rights, Preferences and
Limitations filed with the Secretary of State of the State of Delaware on
October 25, 2002) and (ii) each of the holders of warrants to purchase Common
Stock that were issued by the Company in connection with the Company's issuance
of Series B3 Convertible Redeemable Preferred Stock of the Company (having the
rights and preferences as set forth in that certain Certificate of Designation
of Rights, Preferences and Limitations filed with the Secretary of State of the
State of Delaware on October 25, 2002).

         4. COVENANTS.

            (a) Best Efforts. The parties shall use their best efforts timely to
satisfy each of the conditions described in Section 6 and Section 7 of this
Agreement.

            (b) Form D: Blue Sky Laws. The Company shall file with the SEC a
Form D with respect to the Securities as required under Regulation D and provide
a copy thereof to the Purchasers promptly after such filing. The Company shall,
on or before the Closing Date, take such action as the Company shall reasonably
determine is necessary to qualify the Securities for sale to the Purchasers
pursuant to this Agreement under applicable securities or "blue sky" laws of the
states of the United States or obtain exemption therefrom, and shall provide
evidence of any such action so taken to the Purchasers on or prior to the
Closing Date. Within ten (10) days after the Closing Date, the Company shall
file a Form 8-K with the SEC concerning this Agreement and the transactions
contemplated hereby, which Form 8-K shall attach this Agreement and its Exhibits
as exhibits to such Form 8-K (the "8-K Filing"). From and after the 8-K Filing,
the Company hereby acknowledges that no Purchaser shall be in possession of any
material nonpublic information received from the Company, any of its
subsidiaries or any of its respective officers, directors, employees or agents,
that is not disclosed in the 8-K Filing. The Company shall not, and shall cause
each of its subsidiaries and its and each of their respective officers,
directors, employees and agents not to, provide any Purchaser with any material
nonpublic information regarding the Company or any of its subsidiaries from and
after the 8-K Filing without the express written consent of such Purchaser,
provided, however, that a Purchaser which exercises its rights under Section
4(m) shall be deemed to have given such express written consent. In the event of
a breach of the foregoing covenant by the Company, any of its subsidiaries, or
any of its or their respective officers, directors, employees and agents, in
addition to any other remedy provided herein or in the other Transaction
Documents, a Purchaser shall have the right to make a public disclosure, in the
form of a press release, public advertisement or otherwise, of such material
nonpublic information without the prior approval by the Company, its
subsidiaries, or any of its or their respective officers, directors, employees
or agents. No Purchaser shall have any liability to the Company, its
subsidiaries, or any of its or their respective officers, directors, employees,
shareholders or agents for any such disclosure. Subject to the foregoing,
neither the Company nor any Purchaser shall issue any press releases or any
other public statements with respect to the transactions contemplated hereby;
provided, however, that the Company shall be entitled, without the prior
approval of any Purchaser, to

                                      -15-
<PAGE>
make any press release or other public disclosure with respect to such
transactions (i) in substantial conformity with the 8-K Filing and
contemporaneously therewith and (ii) as is required by applicable law and
regulations (provided that in the case of clause (i) each Purchaser shall be
consulted by the Company in connection with any such press release or other
public disclosure prior to its release).

            (c) Reporting Status. So long as any Purchaser beneficially owns any
of the Securities, the Company shall timely file all reports required to be
filed with the SEC pursuant to the Exchange Act, and the Company shall not
terminate its status as an issuer required to file reports under the Exchange
Act even if the Exchange Act or the rules and regulations thereunder would
permit such termination.

            (d) Use of Proceeds. The Company shall have used the proceeds from
the sale of the Series D Stock and Warrants as set forth in Schedule 4(d).

            (e) Expenses. The Company shall pay to the Purchasers at the
Closing, reimbursement for the out-of-pocket expenses reasonably incurred by the
Purchasers and their affiliates and advisors in connection with the negotiation,
preparation, execution and delivery of this Agreement and the other agreements
to be executed in connection herewith, including, without limitation, the
Purchasers and their affiliates and advisors' reasonable due diligence and
attorneys' fees and expenses (the "EXPENSES"); provided, however, that the
Purchasers shall be permitted to deduct all Expenses from the Purchase Price
payable by the Purchasers hereunder; and provided further that the amount of the
Expenses shall not exceed $37,500 unless prior approval is obtained from the
Company.

            (f) Financial Information. So long as any Purchaser owns any
Securities, if the Company is not required to file reports pursuant to Section
13(a) or 15(d) of the Exchange Act, it will prepare and furnish to the
Purchasers and make publicly available in accordance with Rule 144(c)
promulgated under the Securities Act annual and quarterly financial statements,
together with a discussion and analysis of such financial statements in form and
substance substantially similar to those that would otherwise be required to be
included in reports required by Section 13(a) or 15(d) of the Exchange Act, as
well as any other information required thereby, in the time period that such
filings would have been required to have been made under the Exchange Act.

            (g) Reservation of Shares. The Company currently has authorized and
reserved for the purpose of issuance 15,943,098 shares of Common Stock to
provide for the full conversion of the Series D Stock and issuance of the
Conversion Shares in connection therewith, the full exercise of the Series D-1
Warrants and the issuance of the Warrant Shares underlying the Series D-1
Warrants in connection therewith and as otherwise required by the Series D
Stock, the Series D-1 Warrants and the Registration Rights Agreement
(collectively, the "ISSUANCE Obligations"). In the event such number of shares
becomes insufficient to satisfy the Issuance Obligations, the Company shall take
all necessary action to authorize and reserve such additional shares of Common
Stock necessary to satisfy the Issuance Obligations. On or before September 1,
2003, the Company shall issue the Series D-2 Warrants to the Purchasers, and
further shall take all necessary and desirable action to ensure that the
requisite number of Warrant Shares

                                      -16-
<PAGE>
underlying the Series D-2 Warrants are reserved for issuance, and as otherwise
required by the Series D-2 Warrants and the Registration Rights Agreement.

            (h) Listing. The Company shall maintain, so long as the Purchasers
(or any of its affiliates) own any Securities, the listing of all Conversion
Shares and Warrant Shares, as applicable, from time to time issuable upon
conversion of the Series D Stock and exercise of the Warrants then issued on
each national securities exchange, automated quotation system or electronic
bulletin board on which shares of Common Stock are currently listed. The Company
will use its best efforts to continue the listing and trading of its Common
Stock on the SmallCap Market or on the Nasdaq National Market ("NNM"), the New
York Stock Exchange ("NYSE"), the American Stock Exchange ("AMEX"), the OTC or
the Bulletin Board Exchange (the "BBX") and will comply in all respects with the
reporting, filing and other obligations under the bylaws or rules of the
National Association of Securities Dealers, Inc. (the "NASD"), such exchanges,
or such electronic system, as applicable. The Company shall promptly provide to
the Purchasers copies of any notices it receives regarding the continued
eligibility of the Common Stock for trading on any securities exchange or
automated quotation system on which securities of the same class or series
issued by the Company are then listed or quoted, if any.

            (i) Corporate Existence. So long as the Purchasers beneficially own
any Securities, the Company shall maintain its corporate existence, and in the
event of a merger, consolidation or sale of all or substantially all of the
Company's assets, the Company shall ensure that the surviving or successor
entity in such transaction (i) assumes the Company's obligations under the
Transaction Documents and the agreements and instruments entered into in
connection herewith and therewith regardless of whether or not the Company would
have had a sufficient number of shares of Common Stock authorized and available
for issuance in order to effect the conversion of all the Series D Stock and
exercise in full of all Warrants outstanding as of the date of such transaction
and (ii) except in the event of a merger, consolidation of the Company into any
other corporation, or the sale or conveyance of all or substantially all of the
assets of the Company where the consideration consists solely of cash, the
surviving or successor entity is a publicly traded corporation whose common
stock is listed for trading on the NNM, SmallCap Market, the NYSE , the AMEX or
the OTC.

            (j) No Integrated Offerings. The Company shall not make any offers
or sales of any security (other than the Securities) under circumstances that
would require registration of the Securities being offered or sold hereunder
under the Securities Act or cause this offering of the Securities to be
integrated with any other offering of securities by the Company for purposes of
any stockholder approval provision applicable to the Company or its securities.

            (k) Legal Compliance. The Company shall conduct its business and the
business of its Principal Subsidiaries in compliance with all laws, ordinances
or regulations of governmental entities applicable to such businesses, except
where the failure to do so would not have a Material Adverse Effect.

            (l) [Intentionally Omitted.]

                                      -17-
<PAGE>
            (m) Inspection of Properties and Books. So long as the Purchasers
shall hold any Series D Stock, the Purchasers and its representatives and agents
(collectively, the "INSPECTORS") shall have the right, at the Purchasers'
expense, to visit and inspect any of the properties of the Company and of its
Principal Subsidiaries, to examine the books of account and records of the
Company and of its Principal Subsidiaries, to make or be provided with copies
and extracts therefrom, to discuss the affairs, finances and accounts of the
Company and of its Principal Subsidiaries with, and to be advised as to the same
by, its and their officers and independent public accountants (and by this
provision the Company authorizes such accountants to discuss such affairs,
finances and accounts within the presence of a representative of the Company)
all at such reasonable times and intervals and to such reasonable extent as the
Purchasers may desire; provided, however, that each Inspector shall hold in
confidence and shall not make any disclosure (except to the Purchasers) of any
such information which the Company determines in good faith to be confidential,
and of which determination the Inspectors are so notified, unless (i) the
disclosure of such information is necessary to avoid or correct a material
misstatement or omission in any Registration Statement filed pursuant to the
Registration Rights Agreement, (ii) the release of such information is ordered
pursuant to a subpoena or other order from a court or government body of
competent jurisdiction, or (iii) such information has been made generally
available to the public other than by disclosure in violation of this or any
other agreement. The Purchasers agree that it shall, upon learning that
disclosure of such information is sought in or by a court or governmental body
of competent jurisdiction or through other means, give prompt notice to the
Company and allow the Company, at its expense, to undertake appropriate action
to prevent disclosure of, or to obtain a protective order for, the information
deemed confidential. The Purchasers further acknowledge and agree that by virtue
of the inspections contemplated herein they may come to be in possession of
material non-public information and shall hold such information in confidence
and shall not trade in the securities of the Company until such time as that
information has been disseminated to the public by the Company, provided,
however, that nothing herein shall limit the Company's obligations under the
Registration Rights Agreement, including without limitation, Section 3(f)
thereof.

            (n) [Intentionally Omitted.]

            (o) Pledge of Securities. The Company acknowledges and agrees that
the Securities may be pledged by an Investor (as defined in the Registration
Rights Agreement) in connection with a bona fide margin agreement or other loan
or financing arrangement that is secured by the Securities. The pledge of
Securities shall not be deemed to be a transfer, sale or assignment of the
Securities hereunder, and no Investor effecting a pledge of Securities shall be
required to provide the Company with any notice thereof or otherwise make any
delivery to the Company pursuant to this Agreement or any other Transaction
Document. The Company hereby agrees to execute and deliver such documentation as
a pledgee of the Securities may reasonably request in connection with a pledge
of the Securities to such pledgee by an Investor.

            (p) Variable Securities. The Company shall not, in any manner, issue
or sell any rights, warrants or options to subscribe for or purchase Common
Stock or directly or indirectly convertible into or exchangeable or exercisable
for Common Stock at a price which varies or may vary with the market price of
the Common Stock, including by way of one or more reset(s) to any fixed price,
unless the conversion, exchange or exercise price of any such security

                                      -18-
<PAGE>
is not less than the then applicable Conversion Price (as defined in the
Certificate of Designations and as may be adjusted from time to time) of the
Series D Stock.

            (q) Repurchase of Series D Stock. If, on or before July 17, 2003,
the Company and the Lead Investors have not entered into legally, binding
documentation, in form and substance agreeable to both parties, with respect to
the formation and operation of a joint venture and/or the creation and operation
of an entity to be organized under the laws of Mauritius, the Lead Investors
shall each have the pro rata right to sell to the Company, and the Company shall
have the obligation to purchase from the Lead Investors (the "LEVEL8 ASIA PUT"),
by wire transfer in immediately available funds an amount equal to up to (i)
$1,000,000 in aggregate Face Amount of Series D Stock (as defined in the
Certificate of Designations) as first adjusted pro rata among the Lead Investors
pursuant to their relative liquidation preference of such Series D Stock plus
(ii) an amount equal to the product obtained by (X) $1,000,000, (Y) multiplied
by .05, (Z) multiplied by N/365, where N equals the number of days elapsed from
the date of this Agreement until the date upon which payment to the Lead
Investor by the Company on account of the Level8 Asia Put is received by the
Lead Investor exercising such right to receive payment on account of the Level8
Asia Put.

      In addition to the rights under the Level8 Asia Put described above, if,
on or before May 18, 2003, the Company and Merrill Lynch have not closed a
transaction providing for the sale of Cicero to the Company (as identified on
Schedule 3(k)), the Lead Investors shall each have the pro rata right to sell to
the Company, and the Company shall have the obligation to purchase from the Lead
Investors (the "CICERO PUT"), by wire transfer in immediately available funds an
amount equal to up to (i) $1,000,000 in aggregate Face Amount of Series D Stock
(as defined in the Certificate of Designations) as first adjusted pro rata among
the Lead Investors pursuant to their relative liquidation preference of such
Series D Stock plus (ii) an amount equal to the product obtained by (X)
$1,000,000, (Y) multiplied by .05, (Z) multiplied by N/365, where N equals the
number of days elapsed from the date of this Agreement until the date upon which
payment to the Lead Investor by the Company on account of the Cicero Put is
received by the Lead Investor exercising such right to receive payment on
account of the Cicero Asia Put.

            (r) Restriction of Transactions with Inactive Subsidiaries. Neither
the Company nor any of the Principal Subsidiaries shall make any loans to,
investments in or other payments to, or transfer any assets or rights to, any of
the Inactive Subsidiaries; provided that the Company may make such payments to
or on behalf of the Inactive Subsidiaries necessary to dissolve, liquidate or
otherwise wind up the affairs of the Inactive Subsidiaries which, in the
aggregate, do not exceed $100,000.

            (s) Exchangeability of Certain Shares.

            (i) The Company covenants and agrees that for a period of two years
      following the legal and valid formation (including the completion of all
      legal documentation related thereto) of an entity presently contemplated
      to be formed under the laws of Mauritius by the Company and the Lead
      Investors ("LEVEL8 ASIA"), the Company shall offer to the Lead Investors
      the right to, but the Lead Investors shall not be obligated to, exchange
      (the "OPTIONAL LEVEL8 ASIA

                                      -19-
<PAGE>
      EXCHANGE") up to a whole number of shares of Series D Stock, with a face
      amount of one thousand dollars ($1,000) per share, for shares of Level8
      Asia, in an amount determined by the product derived from the (i) quotient
      obtained by dividing the face amount of the number of shares of Series D
      Stock exchanged, up to a maximum of $800,000 (the "MAXIMUM CONVERSION
      AMOUNT"), (ii) by five hundred dollars ($500) (the "LEVEL8 ASIA SHARES").
      Each of the Lead Investors is entitled to participate in the Optional
      Level8 Asia Exchange up to its pro rata portion, based on its relative
      liquidation preference of the Series D Stock in relation to the other Lead
      Investors, of the Maximum Conversion Amount.

                (1) In order to effect an Optional Level8 ASIA Exchange, the
Lead Investor desiring to effect such action (an "EXCHANGING LEAD INVESTOR")
shall surrender the certificate or certificates representing the shares of
Series D Stock being exchanged at the principal office of the Company, together
with written notice to the Company that such holder elects to exchange such
shares (the "EXCHANGE NOTICE"); provided, however, that in the event such
certificate or certificates have been lost, stolen or destroyed, then the holder
electing to effect such a exchange shall so certify to the Company in its
Exchange Notice, and shall further execute an agreement satisfactory to the
Company to indemnify the Company from any loss incurred by it in connection
therewith. The Exchange Notice shall also state the name or names (with address
or addresses) in which the certificate or certificates for Level8 ASIA Shares
issuable upon such exchange shall be issued. The certificate or certificates for
Level8 ASIA Shares surrendered for exchange shall be accompanied by proper
assignment thereof to the Company or in blank. As promptly as practicable after
delivery of the Exchange Notice, the Company shall issue and deliver to the
Exhanging Lead Investor, or on its written order, at the expense of the Company:
(i) a certificate or certificates, as the Exchanging Lead Investor may request,
representing the number of whole Level8 ASIA Shares issuable upon the exchange
of such shares of Series D Stock in accordance with the provisions of this
Section 4(s) and (ii) if some but not all of the shares of Series D Stock
represented by a certificate surrendered by such holder are exchanged, a new
certificate or certificates representing the number of shares of Series D Stock
which were not exchanged. Such exchange shall be deemed to have been effected
immediately prior to the close of business on the date of such exchange, and at
such time the rights of the holder as holder of the exchanged shares of Series D
Stock shall cease and the person(s) in whose name(s) any certificate(s) for
Level8 ASIA Shares shall be issuable upon such exchange shall be deemed to have
become the holder(s) of record of the shares of Level8 ASIA Shares represented
thereby.

                (2) The Company shall pay any and all taxes that may be imposed
upon it with respect to the issuance and delivery of Level8 ASIA Shares upon the
exchange of shares of Series D Stock in accordance with this Section 4(s).

                (3) The Company further covenants and agrees that such Level8
ASIA Shares, when issued, shall be exchangeable into fully-paid and
nonassessable shares of Common Stock, which shall be registered on the
registration statement contemplated by the Registration Rights Agreement, upon
the terms and conditions of the Series D Stock.

                                      -20-
<PAGE>
            (ii) In the event that either (a) the Company shall not issue the
      Series D-2 Warrants to any Lead Investor pursuant to this Agreement and
      the provisions of Section 4(g) above and such Series D-2 Warrants would be
      exercisable as of November 1, 2003 pursuant to its terms or (b) the Series
      D-2 Warrants shall have been issued and be exercisable as of November 1,
      2003 but are not covered under a registration statement as of November 1,
      2003, then, as soon as is practicable following November 1, 2003, the
      Company shall offer to the Lead Investors in lieu thereof, warrants to
      purchase shares of capital stock of Level8 Asia, in accordance with the
      following parameters and procedures:

                (1) The Company shall issue to the Lead Investors, pro rata
according to their relative liquidation preference of the Series D Stock a
warrant to purchase an aggregate of 700 shares of common stock of Level8 Asia
(the "LEVEL8 ASIA WARRANT"). The Level8 Asia Warrant shall be exercisable solely
by the payment of $1,000 per share of common stock and otherwise shall contain
terms and conditions reasonably satisfactory to the Company and the Lead
Investors , and which are customary for a transaction of this nature.

            (t) [Intentionally Omitted.]

            (u) Lead Investors Standstill. The Lead Investors hereby covenant
and agree to refrain from selling, transferring, or otherwise disposing of any
shares of Common Stock registered on the registration statement contemplated by
the Registration Agreement of even date hereof, for a period of one hundred and
twenty (120) days from the date the registration statement contemplated by
Section 2(a) of such registration statement is declared effective by the United
States Securities and Exchange Commission.

            (v) Other Purchaser Standstill. Each Purchaser (other than the Lead
Investors) hereby covenants and agrees, severally and not jointly, to refrain
from selling, transferring, or otherwise disposing of any shares of Common Stock
or shares of Series D Stock for a period of one hundred and twenty (120) from
the date hereof, except that each Purchaser may sell, transfer, or otherwise
dispose of such number of shares of Common Stock up to no greater than ten
percent (10%) of such number of shares of Common Stock into which the number of
shares of Series D Stock purchased by such Purchaser on the date hereof is
convertible, in accordance with the terms hereof and the other Transaction
Documents, within each thirty (30) day period following the date hereof.

            (w) Level8 ASIA. The Company and the Lead Investors hereby covenant
and agree to use their reasonable best efforts to make and cause the legal and
valid formation of Level8 ASIA.

         5. TRANSFER AGENT INSTRUCTIONS.

            (a) If the Company's transfer agent is participating in the
Depository Trust Company ("DTC") Fast Automated Securities Transfer program, and
so long as the certificates therefor do not bear a legend and the holder of the
Series D Stock or Warrants (any and each a "HOLDER") thereof is not then
required to return such certificate for the placement of a

                                      -21-
<PAGE>
legend thereon, the Company shall cause its transfer agent to electronically
transmit all Conversion Shares and Warrant Shares to the Holder by crediting the
account of the Holder or its nominee with DTC through its Deposit Withdrawal
Agent Commission system ("DTC Transfer"). If the aforementioned conditions to a
DTC Transfer are not satisfied, the Company shall deliver to the Holder physical
certificates representing the Conversion Shares and Warrant Shares, as
applicable. Further, the Holder may instruct the Company to deliver to the
Holder physical certificates representing the Conversion Shares and Warrant
Shares in lieu of delivering such shares by way of DTC Transfer.

            (b) The Company warrants that no instruction other than such
instructions referred to in this Section 5, and stop transfer instructions to
give effect to Section 2(f) hereof in the case of the transfer of the Conversion
Shares or Warrant Shares prior to registration of the Conversion Shares and
Warrant Shares under the Securities Act or without an exemption therefrom, will
be given by the Company to its transfer agent and that the Securities shall
otherwise be freely transferable on the books and records of the Company as and
to the extent provided in this Agreement and the Registration Rights Agreement.
Nothing in this Section shall affect in any way the Purchasers' obligations and
agreement set forth in Section 2(g) hereof to resell the Securities pursuant to
an effective registration statement or under an exemption from the registration
requirements of applicable securities law.

            (c) If the Purchasers provide the Company and the transfer agent
with an opinion of counsel, which opinion of counsel shall be in form, substance
and scope customary for opinions of counsel in comparable transactions, to the
effect that the Securities to be sold or transferred may be sold or transferred
pursuant to an exemption from registration, or the Purchasers provide the
Company with reasonable assurances that such Securities may be sold under Rule
144, the Company shall permit the transfer and, in the case of the Conversion
Shares and Warrant Shares, promptly instruct its transfer agent to issue one or
more certificates in such name and in such denominations as specified by the
Purchasers.

         6. CONDITIONS TO THE COMPANY'S OBLIGATION TO SELL.

      The obligation of the Company hereunder to issue and sell the Series D
Stock and Series D-1 Warrants to the Purchasers hereunder is subject to the
satisfaction, at or before the Closing, of each of the following conditions
thereto, provided that these conditions are for the Company's sole benefit and
may be waived by the Company at any time in its sole discretion:

            (a) Each Purchaser shall have delivered the Purchase Price in
accordance with Section 1(a) above.

            (b) The representations and warranties of the Purchasers shall be
true and correct as of the date when made and as of the Closing Date as though
made at that time (except for representations and warranties that speak as of a
specific date, which representations and warranties shall be true and correct as
of such date), and the Purchasers shall have performed, satisfied and complied
in all material respects with the covenants, agreements and conditions required
by this Agreement to be performed, satisfied or complied with by the Purchasers
at or prior to the Closing Date.

                                      -22-
<PAGE>

                  (c) No statute, rule, regulation, executive order, decree,
ruling or injunction shall have been enacted, entered, promulgated or endorsed
by any court or governmental authority of competent jurisdiction or any
self-regulatory organization having authority over the matters contemplated
hereby which prohibits the consummation of any of the transactions contemplated
by this Agreement.

            7. CONDITIONS TO THE PURCHASERS' OBLIGATION TO PURCHASE.

         The obligation of the Purchasers hereunder to purchase the Series D
Stock and the Series D-1 Warrants from the Company hereunder is subject to the
satisfaction, at or before the Closing Date, of each of the following
conditions, provided that such conditions are for the Purchasers' sole benefit
and may be waived by the Purchasers at any time in such Purchaser's sole
discretion:

                  (a) The Company shall have executed this Agreement and the
other Transaction Documents and delivered executed original copies of the same
to the Purchasers.

                  (b) The Company shall have delivered to the Purchasers duly
executed certificates representing such Series D Stock and Series D-1 Warrants
(each in such denominations as such Purchaser shall request) in accordance with
Section 1(a) above.

                  (c) The Common Stock shall continue to be traded on the
Bulletin Board and trading in the Common Stock (or on the Bulletin Board
generally) shall not have been suspended by the SEC or such Bulletin Board
market.

                  (d) The representations and warranties of the Company shall be
true and correct as of the date when made and as of the Closing Date as though
made at that time (except for representations and warranties that speak as of a
specific date, which representations and warranties shall be true and correct as
of such date) and the Company shall have performed, satisfied and complied in
all material respects with the covenants, agreements and conditions required by
this Agreement to be performed, satisfied or complied with by the Company at or
prior to the Closing Date. The Purchasers shall have received a certificate,
executed by the Chief Executive Officer of the Company after reasonable
investigation, dated as of the Closing Date to the foregoing effect and as to
such other matters as may reasonably be requested by the Purchasers.

                  (e) No statute, rule, regulation, executive order, decree,
ruling, injunction, action or proceeding shall have been enacted, entered,
promulgated or endorsed by any court or governmental authority of competent
jurisdiction or any self-regulatory organization having authority over the
matters contemplated hereby which questions the validity of, challenges or
prohibits the consummation of, any of the transactions contemplated by this
Agreement.

                  (f) The Purchasers shall have received an opinion of the
Company's counsel, dated as of the Closing Date, in form, scope and substance
reasonably satisfactory to the Purchasers and in substantially the form of
Exhibit F attached hereto.

                                      -23-
<PAGE>
                  (g) There shall have been no material adverse changes and no
material adverse developments in the business, properties, operations,
prospects, financial condition or results of operations of the Company and its
Principal Subsidiaries, taken as a whole, since the date hereof, and no
information, of which the Purchasers are not currently aware, shall come to the
attention of the Purchasers that is materially adverse to the Company.

                  (h) The Purchasers shall have received a copy of resolutions,
duly adopted by the Board of Directors of the Company, which shall be in full
force and effect at the time of the Closing, authorizing the execution, delivery
and performance by the Company of this Agreement and the other Transaction
Documents and the consummation by the Company of the transactions contemplated
hereby and thereby, certified as such by the Secretary or Assistant Secretary of
the Company, and such other documents they reasonably request in connection with
the Closing.

                  (i) The Company shall have delivered to such Purchaser a
letter from the Company's transfer agent certifying the number of shares of
Common Stock outstanding as of a date within five days of the Closing Date.

                  (j) The Company shall have obtained, in form and substance
satisfactory to the Purchasers, agreements from the each holder of the Company's
Series A3 Convertible Redeemable Preferred Stock and each holder of the
Company's Series B3 Convertible Redeemable Preferred Stock to refrain from
selling, transferring, or otherwise disposing of any shares of Common Stock for
a period of one hundred and twenty (120) days from the date the registration
statement contemplated by Section 2(a) of the Registration Rights Agreement is
declared effective by the United States Securities and Exchange Commission.

                  (k) The Company shall have obtained, in form and substance
satisfactory to the Purchasers, a waiver from Bank Hapoalim (the "BANK") to the
effect that the Bank waives any rights it otherwise would have upon the
occurrence of an event of default under the Promissory Note executed by the
Company in favor of the Bank, dated as of September 28, 2001, as a result of the
Company's Common Stock having been delisted from the Nasdaq SmallCap Market.

                  (l) The Company will obtain an executed letter agreement
relating to the sale of Cicero intellectual property from Merrill, Lynch,
Pierce, Fenner & Smith Incorporated, substantially the form of Exhibit G
attached hereto.

                  (m) [Intentionally Omitted.]

                  (n) As of the Closing Date, the Company shall have obtained
from any and all third parties that (i) have rights to receive any dividend (in
cash, in-kind or otherwise) and/or (ii) a right to have a security of the
Company redeemed, in each case in the event the Common Stock is not listed on
the Nasdaq SmallCap Market, the Nasdaq National Market, the American Stock
Exchange and the New York Stock Exchange, waivers of any such rights in form and
substance satisfactory to the Purchasers.

                                      -24-
<PAGE>
                  (o) As of the Closing Date, the Company shall have obtained a
waiver, in form and substance satisfactory to the Purchasers, to the effect that
all holders of the Company's Series A3 Convertible Redeemable Preferred Stock
(the "SERIES A3 PREFERRED STOCK") and Series B3 Convertible Redeemable Preferred
Stock (the "SERIES B3 PREFERRED STOCK") shall waive any and all rights they may
otherwise have upon the Company exceeding the Issuance Cap (as that term is
defined both in the Company's Certificate of Designation of Rights, Preferences
and Limitations of Preferred Stock pertaining to the Series A3 Preferred Stock
and the Company's Certificate of Designation of Rights, Preferences and
Limitations of Preferred Stock pertaining to the Series B3 Preferred Stock) as a
result of the transactions contemplated hereby and by the other Transaction
Documents, and shall also expressly agree that the transactions contemplated
hereby and by the other Transaction Documents do not and will not cause the
Company to exceed such Issuance Cap.

            8. GOVERNING LAW; MISCELLANEOUS.

                  (a) Governing Law; Jurisdiction. This Agreement shall be
governed by and construed in accordance with the laws of the State of Delaware
applicable to contracts made and to be performed in the State of Delaware. The
Company and the Purchasers irrevocably consent to the jurisdiction of the United
States federal courts and the state courts located in the County of New Castle,
State of Delaware, in any suit or proceeding based on or arising under this
Agreement and irrevocably agree that all claims in respect of such suit or
proceeding may be determined in such courts. The Company irrevocably waives the
defense of an inconvenient forum to the maintenance of such suit or proceeding.
The Company further agrees that service of process upon the Company mailed by
first class mail shall be deemed in every respect effective service of process
upon the Company in any such suit or proceeding. Nothing herein shall affect the
right of the Purchasers to serve process in any other manner permitted by law.
The Company agrees that a final non-appealable judgment in any such suit or
proceeding shall be conclusive and may be enforced in other jurisdictions by
suit on such judgment or in any other lawful manner.

                  (b) Counterparts. This Agreement may be executed in two or
more counterparts, all of which shall be considered one and the same agreement
and shall become effective when counterparts have been signed by each party and
delivered to the other party. This Agreement, once executed by a party, may be
delivered to the other parties hereto by facsimile transmission of a copy of
this Agreement bearing the signature of the party so delivering this Agreement.
In the event any signature is delivered by facsimile transmission, the party
using such means of delivery shall cause the manually executed execution page(s)
hereof to be physically delivered to the other party within five (5) days of the
execution hereof, provided that the failure to so deliver any manually executed
execution page shall not affect the validity or enforceability of this
Agreement.

                  (c) Headings. The headings of this Agreement are for
convenience of reference and shall not form part of, or affect the
interpretation of, this Agreement.

                                      -25-
<PAGE>
                  (d) Severability. If any provision of this Agreement shall be
invalid or unenforceable in any jurisdiction, such invalidity or
unenforceability shall not affect the validity or enforceability of the
remainder of this Agreement or the validity or enforceability of this Agreement
in any other jurisdiction.

                  (e) Entire Agreement; Amendments. This Agreement and the
instruments referenced herein contain the entire understanding of the
Purchasers, the Company, their affiliates and persons acting on their behalf
with respect to the matters covered herein and therein and, except as
specifically set forth herein or therein, neither the Company nor the Purchasers
make any representation, warranty, covenant or undertaking with respect to such
matters. No provision of this Agreement may be waived other than by an
instrument in writing signed by the party to be charged with enforcement and no
provision of this Agreement may be amended other than by an instrument in
writing signed by the Company and the Purchasers.

                  (f) Notices. Any notices required or permitted to be given
under the terms of this Agreement shall be sent by certified or registered mail
(return receipt requested) or delivered personally, by responsible overnight
carrier or by confirmed facsimile, and shall be effective five (5) days after
being placed in the mail, if mailed, or upon receipt or refusal of receipt, if
delivered personally or by responsible overnight carrier or confirmed facsimile,
in each case addressed to a party. The addresses for such communications shall
be:

                               If to the Company:

                              Level 8 Systems, Inc.
                              8000 Regency Parkway
                              Cary, North Carolina 27511
                              Facsimile: (919) 380-5090
                              Attn: John P. Broderick

                              with a copy simultaneously transmitted by like
                              means to:

                              Powell, Goldstein, Frazer & Murphy LLP
                              191 Peachtree Street; 16th Floor
                              Atlanta, Georgia 30319
                              Facsimile: (404) 572-6999
                              Attn:  Scott D. Smith, Esq.

            If to the Purchasers, to the address set forth under each
Purchaser's name on the execution page hereto, and, if to SDS, with a copy
simultaneously transmitted by like means to:

                              Drinker Biddle & Reath LLP
                              One Logan Square
                              18th & Cherry Streets
                              Philadelphia, PA  19103
                              Facsimile: (215) 988-2757
                              Attn:  Stephen T. Burdumy, Esq.

                                      -26-
<PAGE>
            Each party shall provide notice to the other party of any change in
address.

                  (g) Successors and Assigns. This Agreement shall be binding
upon and inure to the benefit of the parties and their successors and assigns.
Except as provided herein or therein, neither the Company nor the Purchasers
shall assign this Agreement or any rights or obligations hereunder.
Notwithstanding the foregoing, each Purchaser may assign its rights hereunder to
any of its "affiliates," as that term is defined under the Exchange Act, without
the consent of the Company or to any other person or entity with the consent of
the Company, which consent shall not be unreasonably withheld. This provision
shall not limit the Purchasers' right to transfer the Securities pursuant to the
terms of the Certificate of Designations, the Warrants and this Agreement or to
assign the Purchasers' rights hereunder or thereunder or under the Registration
Rights Agreement or the Escrow Agreement to any such transferee.

                  (h) Third Party Beneficiaries. This Agreement is intended for
the benefit of the parties hereto and their respective permitted successors and
assigns, and is not for the benefit of, nor may any provision hereof be enforced
by, any other person.

                  (i) Survival. The representations and warranties of the
Company and the agreements and covenants set forth in Sections 3, 4, 5 and 8
hereof shall survive following the Closing notwithstanding any due diligence
investigation conducted by or on behalf of the Purchasers, except that, in the
case of representations and warranties such survival will be limited to the
period of four (4) years following the Closing Date on which they were made or
deemed to have made (other than with respect to any claim by a third party
against the party to this Agreement who seeks to assert a claim based on such
representations and warranties). Moreover, none of the representations and
warranties made by the Company herein shall act as a waiver of any rights or
remedies the Purchasers may have under applicable U.S. federal or state
securities laws. The Company shall indemnify and hold harmless the Purchasers
and each Purchaser's officers, directors, employees, partners, members, agents
and affiliates for all losses or damages arising as a result of or related to
any breach or alleged breach by the Company of any of its representations or
covenants set forth herein, including advancement of expenses as they are
incurred.

                  (j) Publicity. The Company and the Purchasers shall have the
right to approve before issuance any press releases, SEC or, to the extent
applicable, NASD filings, or any other public statements with respect to the
transactions contemplated hereby; provided, however, that the Company shall be
entitled, without the prior approval of the Purchasers, to make any press
release or SEC or, to the extent applicable, NASD filings with respect to such
transactions as is required by applicable law and regulations (although the
Purchasers shall be consulted by the Company in connection with any such press
release and filing prior to its release and shall be provided with a copy
thereof and must provide specific consent to the use of their name in connection
therewith).

                  (k) Further Assurances. Each party shall do and perform, or
cause to be done and performed, all such further acts and things, and shall
execute and deliver all such other agreements, certificates, instruments and
documents, as the other party may reasonably

                                      -27-
<PAGE>
request in order to carry out the intent and accomplish the purposes of this
Agreement and the consummation of the transactions contemplated hereby.

                  (l) Indemnification. In consideration of each Purchaser's
execution and delivery of the Transaction Documents and acquiring the Securities
thereunder and in addition to all of the Company's other obligations under the
Transaction Documents, the Company shall defend, protect, indemnify and hold
harmless each Purchaser and each other holder of the Securities and all of their
stockholders, partners, members, officers, directors, employees and direct or
indirect investors and any of the foregoing persons' agents or other
representatives (including, without limitation, those retained in connection
with the transactions contemplated by this Agreement) (collectively, the
"INDEMNITEES") from and against any and all actions, causes of action, suits,
claims, losses, costs, penalties, fees, liabilities and damages, and expenses in
connection therewith (irrespective of whether any such Indemnitee is a party to
the action for which indemnification hereunder is sought), and including
reasonable attorneys' fees and disbursements (the "INDEMNIFIED LIABILITIES"),
incurred by any Indemnitee as a result of, or arising out of, or relating to (i)
any misrepresentation or breach of any representation or warranty made by the
Company in the Transaction Documents or any other certificate, instrument or
document contemplated hereby or thereby, (ii) any breach of any covenant,
agreement or obligation of the Company contained in the Transaction Documents or
any other certificate, instrument or document contemplated hereby or thereby or
(iii) any cause of action, suit or claim brought or made against such Indemnitee
by a third party (including for these purposes a derivative action brought on
behalf of the Company) and arising out of or resulting from (A) the execution,
delivery, performance or enforcement of the Transaction Documents or any other
certificate, instrument or document contemplated hereby or thereby, (B) any
transaction financed or to be financed in whole or in part, directly or
indirectly, with the proceeds of the issuance of the Securities, or (C) any
disclosure made by such Purchaser pursuant to Section 4(b) or Section 4(m)
hereof, expect that the Company shall not be required to defend, protect,
indemnify or hold harmless any Purchaser for any material misstatement or
omission in any disclosure made by the any Purchaser pursuant to Section 4(b) or
Section 4(m). To the extent that the foregoing undertaking by the Company may be
unenforceable for any reason, the Company shall make the maximum contribution to
the payment and satisfaction of each of the Indemnified Liabilities which is
permissible under applicable law. Except as otherwise set forth herein, the
mechanics and procedures with respect to the rights and obligations under this
Section 9(l) shall be the same as those set forth in Section 6 of the
Registration Rights Agreement; provided that, if Section 6 of the Registration
Rights Agreement is applicable to a particular circumstance, Section 9(l) hereof
shall not also apply.

                  (m) Payment Set Aside. To the extent that the Company makes a
payment or payments to the Purchasers hereunder or pursuant to any of the other
Transaction Documents or the Purchasers enforce or exercise their rights
hereunder or thereunder, and such payment or payments or the proceeds of such
enforcement or exercise or any part thereof are subsequently invalidated,
declared to be fraudulent or preferential, set aside, recovered from, disgorged
by or are required to be refunded, repaid or otherwise restored to the Company,
a trustee, receiver or any other person under any law (including, without
limitation, any bankruptcy law, state or federal law, common law or equitable
cause of action), then to the extent of any such restoration the obligation or
part thereof originally intended to be satisfied

                                      -28-
<PAGE>
shall be revived and continued in full force and effect as if such payment had
not been made or such enforcement or setoff had not occurred.

                  (n) Joint Participation in Drafting. Each party to this
Agreement has participated in the negotiation and drafting of this Agreement and
the other Transaction Documents. As such, the language used herein and therein
shall be deemed to be the language chosen by the parties hereto to express their
mutual intent, and no rule of strict construction will be applied against any
party to this Agreement.

                  (o) Equitable Relief. The Company acknowledges that a breach
by it of its obligations hereunder will cause irreparable harm to the Purchasers
by vitiating the intent and purpose of the transactions contemplated hereby.
Accordingly, the Company acknowledges that the remedy at law for a breach of its
obligations hereunder (including, but not limited to, its obligations pursuant
to Section 5 hereof) will be inadequate and agrees, in the event of a breach or
threatened breach by the Company of the provisions of this Agreement (including,
but not limited to, its obligations pursuant to Section 5 hereof), that the
Purchasers shall be entitled, in addition to all other available remedies, to an
injunction restraining any breach and requiring immediate issuance and transfer
of the Securities, without the necessity of showing economic loss and without
any bond or other security being required.

                  (p) Knowledge. As used in this Agreement, the term "knowledge"
of any person or entity shall mean and include (i) actual knowledge and (ii)
that knowledge which a reasonable prudent business person could have obtained in
the management of his or her business affairs after making due inquiry and
exercising due diligence which a prudent business person should have made or
exercised, as applicable, with respect thereto.

                  (q) Understanding Among Purchasers. It is acknowledged by each
Purchaser that no Purchaser has acted as an agent of any other Purchaser in
connection with making its investment hereunder and that no Purchaser shall be
acting as an agent of any other Purchaser in connection with monitoring its
investment hereunder. It is further acknowledged by each of the other Purchasers
that SDS has retained Drinker Biddle & Reath LLP ("Drinker Biddle") to act as
its counsel in connection with the transactions contemplated hereby and under
the other Transaction Documents and that Drinker Biddle has not acted as counsel
for any of the other Purchasers in connection therewith and that none of the
other Purchasers have the status of a client of Drinker Biddle for conflict of
interest or other purposes as a result thereof.

                  [REMAINDER OF PAGE LEFT BLANK INTENTIONALLY]

                                      -29-
<PAGE>
        IN WITNESS WHEREOF, the undersigned Purchasers and the Company have
caused this Agreement to be duly executed as of the date first above written.

               LEVEL 8 SYSTEMS, INC.

               By: __________________________________
               Name: ________________________________
               Title: _______________________________

               PURCHASERS:

                    [SIGNATURES CONTAINED ON ATTACHED PAGES]

                                      -30-
<PAGE>
               SDS MERCHANT FUND, L.P.,
                a Delaware limited partnership
                      By SDS Capital Partners L.L.C., its managing member

               By: __________________________________
               Name: ________________________________
               Title: _______________________________
               Address:      c/o SDS Capital LLC
                             53 Forest Avenue, Second Floor
                             Old Greenwich, CT 06870
                             Facsimile:  (203) 967-5851
                             Attn: Steven Derby

               DMG LEGACY FUND LLC,

                      By DMG Advisors LLC, its managing member

               By: __________________________________
               Name: ________________________________
               Title: _______________________________
               Address:      c/o DMG Advisors LLC
                             53 Forest Ave., Ste 202
                             Old Greenwich, CT 06870
                             Attn: Kevin Johnson Director of Operations

               DMG LEGACY INSTITUTIONAL FUND LLC,
                      By DMG Advisors LLC, its managing member

               By: __________________________________
               Name: ________________________________
               Title: _______________________________
               Address:      c/o DMG Advisors LLC
                             53 Forest Ave., Ste 202
                             Old Greenwich, CT 06870
                             Attn: Kevin Johnson Director of Operations

               DMG LEGACY INTERNATIONAL LTD.,
                      By DMG Advisors LLC, its managing member

               By: __________________________________
               Name: ________________________________
               Title: _______________________________
               Address:      c/o DMG Advisors LLC
                             53 Forest Ave., Ste 202
                             Old Greenwich, CT 06870

                                      -31-
<PAGE>
                             Attn: Kevin Johnson Director of Operations

               PURCHASERS (CONT.):

               IKE DWECK

               By: __________________________________
               Name: ________________________________
               Address:      46 Ocean Ave
                             Deal, NJ 07723

               BRUCE MILLER

               By: __________________________________
               Name: ________________________________
               Address:      PO Box 245
                             Nantucket, MA 02554

               JIM STEVENS

               By: __________________________________
               Name: ________________________________
               Address:      8818 Ashridge Park Drive
                             Spring, TX 77379

               FRED MACK 4/30/92 TRUST

               By: __________________________________
               Name: ________________________________
               Title: _______________________________
               Address:      2115 Linwood Ave.
                             Fort Lee, NJ 07024

               VERTICAL VENTURES INVESTMENTS LLC

               By: __________________________________
               Name: ________________________________
               Title: _______________________________
               Address:      c/o Vertical Ventures
                             900 Third Avenue, 26th Floor
                             New York, New York 10022
                             Attn: Joshua Silverman
                             Fax: (646) 274-1728

                                      -32-
<PAGE>
               PURCHASERS (CONT.):

               JOSEPH SHELANSKI

               By: __________________________________
               Name: ________________________________
               Address:      710 Mill Creek Rd.
                             Gladwyne, PA 19035

               C. GLEN & JOAN DUGDALE

               By: __________________________________
               Name: ________________________________
               Address:      3609 Centerville Road
                             Greenville, DE 19807

               JAMES COMPTON

               By: __________________________________
               Name: ________________________________
               Address:      2619 Albans
                             Houston, Texas 77005

               DELPHI PARTNERS LIMITED

               By: __________________________________
               Name: ________________________________
               Title: _______________________________
               Address:      c/o Bruce D. Miller; General Partner
                             P.O. Box 246
                             Nantucket, MA 02554

                                      -33-
<PAGE>
                                  SCHEDULE 1(A)
                                   PURCHASERS

<TABLE>
<CAPTION>
                                              NUMBER OF SHARES
                                                OF SERIES D
NAME AND                                       PREFERRED STOCK   SERIES D-1   SERIES D-2
ADDRESS OF PURCHASER             RESIDENCE     AT CLOSING DATE    WARRANTS     WARRANTS    PURCHASE PRICE
--------------------             ---------     ---------------    --------     --------    --------------
<S>                              <C>          <C>                <C>          <C>          <C>
SDS Merchant Fund, L.P.          Delaware          1,500          1,767,187    707,813       $1,500,000
c/o SDS Capital LLC
53 Forest Avenue, Second Floor
Old Greenwich, CT 06870
Attn: Steven Derby

DMG Legacy Fund LLC              Delaware             80           94,250       37,750          $80,000
c/o DMG Advisors LLC
53 Forest Ave., Ste 202
Old Greenwich, CT 06870
Attn: Kevin Johnson Director
of Operations

DMG Legacy Institutional Fund    Delaware            720          848,250      339,750         $720,000
LLC
c/o DMG Advisors LLC
53 Forest Ave., Ste 202
Old Greenwich, CT 06870
Attn: Kevin Johnson Director
of Operations

DMG Legacy International Ltd     International       755          889,484      356,266         $755,000
c/o DMG Advisors LLC
53 Forest Ave., Ste 202
Old Greenwich, CT 06870
Attn: Kevin Johnson Director
of Operations

Ike Dweck                        New Jersey           25           29,453       11,797          $25,000
46 Ocean Avenue
Deal, NJ 07723

Bruce Miller                     Massachusetts        50           58,906       23,594          $50,000
PO Box 246
Nantucket, MA 02554

Jim Stevens                      Texas                75           88,359       35,391          $75,000
8818 Ashridge Park Drive
Spring, TX 77379

Fred Mack 4/30/92 Trust          New Jersey           65           76,578       30,672          $65,000
2115 Linwood Ave.
Fort Lee, NJ 07024

Vertical Ventures Investments,   Delaware            150          176,719       70,781         $150,000
LLC
650 Fifth Avenue; 6th Floor
New York, New York 10019

Joseph Shelanski                 Pennsylvania         30           35,344       14,156          $30,000
710 Mill Creek Rd.
Gladwyne, PA 19035

C Glen & Joan Dugdale            Delaware             30           35,344       14,156          $30,000
3609 Centerville Road
Greenville, DE 19807

James Compton                    Texas                25           29,453       11,797          $25,000
2619 Albans
Houston, Texas 77005

Delphi Partners Limited          Massachusetts        25           29,453       11,797          $25,000
c/o Bruce D. Miller; General
Partner
P.O. Box 246
Nantucket, MA 02554
</TABLE>

                                      -34-
<PAGE>
<TABLE>
<CAPTION>
                                              NUMBER OF SHARES
                                                OF SERIES D
NAME AND                                       PREFERRED STOCK   SERIES D-1   SERIES D-2
ADDRESS OF PURCHASER             RESIDENCE     AT CLOSING DATE    WARRANTS     WARRANTS    PURCHASE PRICE
--------------------             ---------     ---------------    --------     --------    --------------
<S>                              <C>          <C>                <C>          <C>          <C>
TOTAL                                              3,530          4,158,780   1,665,720      $3,530,000
</TABLE>

                                      -35-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00049-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00049-of-00352.parquet"}]]